Conformational dynamics associated with calcium binding to calcium transducers by Dhulipala, Gangadhar
Florida International University
FIU Digital Commons
FIU Electronic Theses and Dissertations University Graduate School
7-8-2010
Conformational dynamics associated with calcium
binding to calcium transducers
Gangadhar Dhulipala
Florida International University
Follow this and additional works at: http://digitalcommons.fiu.edu/etd
Part of the Chemistry Commons
This work is brought to you for free and open access by the University Graduate School at FIU Digital Commons. It has been accepted for inclusion in
FIU Electronic Theses and Dissertations by an authorized administrator of FIU Digital Commons. For more information, please contact dcc@fiu.edu.
Recommended Citation
Dhulipala, Gangadhar, "Conformational dynamics associated with calcium binding to calcium transducers" (2010). FIU Electronic
Theses and Dissertations. 2794.
http://digitalcommons.fiu.edu/etd/2794
FLORIDA INTERNATIONAL UNIVERSITY
Miami, Florida
CONFORMATIONAL DYNAMICS ASSOCIATED WITH CALCIUM BINDING TO
CALCIUM TRANSDUCERS
A thesis submitted in partial fulfillment of the
requirements for the degree of
MASTER OF SCIENCE
in
CHEMISTRY
by
Gangadhar Dhulipala
2010
To: Dean Kenneth Furton
College of Arts and Sciences
This thesis, written by Gangadhar Dhulipala, and entitled Conformational Dynamics
Associated with Calcium Binding to Calcium Transducers, having been approved in
respect to style and intellectual content, is referred to you for judgment.
We have read this thesis and recommend that it be approved.
Xiaotang Wang
David C. Chatfield
Jaroslava Miksovska, Major Professor
Date of Defense: July 08, 2010
The thesis of Gangadhar Dhulipala is approved.
Dean Kenneth Furton
College of Arts and Sciences
Interim Dean Kevin O'Shea
University Graduate School
Florida International University, 2010
ii
DEDICATION
To all my mentors, friends, and my parents, Subba Rao Dhulipala and Ramasubbul
Dhulipala
iii
ACKNOWLEDGMENTS
I would like to express my sincere gratitude to my major professor, Dr. Jaroslava
Miksovska, for giving me the opportunity to work on this exciting project and for her
support for the last three years. A special thanks to my committee members Dr. David C.
Chatfield and Dr. Xiaotang Wang for their valuable suggestions and comments.
I would like to acknowledge Xiaoduo from Dr. Leng's lab for helping me with the
microbiology techniques. Thanks to my father Subba Rao, my mother Ramasubbulu, my
brother Muralidhar Dhulipala, and my relatives Venu Babu Gorantla, Sarvani Gorantla,
Somaiah Pendurthi, and Uma Devi Pendurthi for their best wishes to fulfill my dreams. I
would like to thank my loving sisters Rohini Kolluri, Kalpana and my friends Chotu,
Setu, Swathi, Vamsi, Sujatha, Vijay, Sandeep, and Suman for their care and moral
support throughout my stay at FIU.
Finally, I would like to thank my labmates Simona, Luisana, Khoa and Mimy for their
care and affection. Special thanks to Dr. Yong Cai and all the staff of the Chemistry
Department at FIU. Once again, I would like to thank my major professor, Dr. Jaroslava
Miksovska, for all her suggestions and guidance in completing my thesis.
iv
ABSTRACT OF THE THESIS
CONFORMATIONAL DYNAMICS ASSOCIATED WITH CALCIUM BINDING TO
CALCIUM TRANSDUCERS
by
Gangadhar Dhulipala
Florida International University, 2010
Miami, Florida
Professor Jaroslava Miksovska, Major Professor
The Ca' association to calcium binding proteins (CaBPs) represents an essential step in
Ca2+ signal transduction. This study presents a characterization of Ca interactions with
two CaBPs, calmodulin and DREAM, using time-resolved photothermal and
fluorescence techniques. Calcium binding to the calmodulin C-terminal domain is
associated with a volume change of 40 mL molP and an enthalpy change of 35 16 kcal
moP-. These parameters are consistent with the Ca triggered exposure of hydrophobic
patches on the calmodulin surface. Also, the rate limiting step for Ca binding to
calmodulin is the closed-to-open transition of the C-terminal domain that occurs with a
lifetime of 400 gs. Unlike calmodulin, DREAM exists in a dynamic equilibrium of two
conformations and Ca binding shifts the equilibrium towards a more compact
conformation. These data clearly demonstrate that conformational dynamics play a
crucial role in the transmission of Ca2+ signals.
v
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1.0, Calcium binding proteins
1.1. Calcium
Calcium is an essential bioelement that plays a vital role in the metabolism and
physiology of eukaryotes (Clapham et al. 2007, Berridge et al. 2000). Calcium is found in
intracellular space, extracellular fluids, and bones and teeth. In bones and teeth, Ca2+ is
found in the form of hydroxyapatites (Ganong et al. 2005). A constant Ca2+ concentration
of - 2 mM is maintained in the blood (Clapham et al. 2007) and its deviation from the
normal level may lead to serious health problems such as hypocalcaemia or
hypercalcaemia (Ganong et al. 2005). To maintain Ca homeostasis, there is a frequent
exchange of Ca2+ between the blood and other parts of the body such as small intestine,
bones, and kidneys as presented in Scheme 1 (Ganong et al. 2005).
INTESTINE BOOD - > BONE
KIDNEY
Scheme 1:
Regulation of intracellular Ca+ concentration is more complex, since this concentration
is tightly controlled and oscillates from nM level in the resting state to mM level in the
activated state (Clapham et al. 1995). Numerous membrane proteins such as pumps, ion
channels, and ion exchangers take part in controlling the Ca2+concentration between the
1
resting and the activated state, as shown in Figure 1.1 (Gifford et al. 2007, Berridge et al.
1997, Clapham et al. 2007).
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Figure 1.1. The mechanism of the control of intracellular Ca2+ concentration during "ON"
and "OFF" state. Figure adopted from Gifford et al. (Gifford et al. 2007).
Membrane protein complexes such as voltage operated ion channels (VOCs), receptor
operated ion channels (ROCs), store operated Ca2+ channels (SOCs), and secondary
messenger operated Ca2+ channels (SMOCs) allow for influx of Ca2+ into the cytoplasm
(Gifford et al. 2007). The release of Ca2+ from internal Ca 2+ stores like the endoplasmic
and sarcoplasmic reticulum occurs through ryanodine receptors (RYR) and ionositol
2
triphoosphate receptors (InsP3R), and the process is triggered by secondary messengers
like ionositol triphosphate (InsP 3) and cyclic ADP-ribose (cADPR) that are generated
during the signaling cascades (Berridge et al. 1997, Gifford et aL. 2007). On the other
hand, during "OFF" reactions, elevated Ca2+ concentration decreases to the resting level
through action of sodium Ca2+ exchangers (NCX), and plasma membrane Ca2+ ATPases
(PMCAs) that are found within the plasma membrane (Gifford et al. 2007, Clapham et al.
2007). Several other ion channels like sarco-endoplasmic calcium ATPases (SERCAs),
Ca2+ uniporters, and H+/Ca2+ exchangers facilitates Ca2+ entry into the internal stores like
mitochondria, endoplasmic and sarcoplasmic reticulum (Gifford et al. 2007, Clapham et
al. 2007, Clapham et al. 1995).
1.2. Calcium as a secondary messenger
A variety of cellular processes are regulated by change in Ca concentration, ranging
from cell division to apoptosis (Clapham et al. 1995). Rapid fluctuations in Ca2+
concentration, so called Ca spikes, occur within the cell and regulate various
intracellular functions like muscle contraction, exocytosis, energy metabolism,
chemotaxis, activity of gated ion channels, secretion of neurotransmitters, and hormones
secretion, gene transcription, and enzymatic activity of kinases and phosphatases as
depicted in Figure 1.2 (Ellis-Davis et al. 2009).
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Figure 1.2. Various processes regulated by Ca2+ in the body.
In particular, Ca plays a prominent role in muscle contraction. Binding of Ca2+ to
troponin C triggers muscle contraction by facilitating the interactions between actin and
myosin, the main components of the myofilament (Ellis-Davis et al. 2008, Dantzig et al.
1998). Calcium has an important role in neuronal signal transmission since changes in
Ca2+ concentration control release of neurotransmitters such as acetylcholine (Zucker et
al. 1993, Berridge et al. 1998). In addition, Ca2+ regulates, either directly or through Ca2+
transducers, activity of ion channels, like Ca 2' dependent K+ channels that are involved in
the contraction of vascular smooth muscle (Ganong et al. 2005). Calcium participates in
activation of enzymes like pyruvate dehydrogenase complex involved in energy
metabolism (Ganong et al. 2005). Apart from the processes described above, Ca2 + is
involved in the regulation of other important physiological processes like blood clotting
and bone and teeth formation (Ganong et al. 2005).
4
1.3. Calcium binding structural motif
Ca2+ participates in regulation of the above mentioned processes by binding to a group of
intracellular proteins called Ca2+ binding proteins (CaBPs). All CaBPs contains one of
three types of Ca2+ binding structural motifs: the C2-domain found in synaptogamins,
annexins and the EF-hand motif found in more than 2000 proteins (Nalefski et al. 1996,
Gereke et al. 2002, Gifford et al. 2007).
1.3.1. C2-domain
The C2-domain is a conserved functional domain consisting of 130 residues. Structural
studies show that it contains eight strands divided into two pairs that are arranged in
anti-parallel fashion like a j-sandwich (Nalfeski et al. 1996., Essen et al. 1996). These
two pairs are connected by three loops at the top and four loops at the bottom of the $-
sandwich as shown in Figure 1.3. The three top loops can bind up to two Ca ions. Each
Ca2+ ion in the C2-domain is coordinated by seven ligands, five of which come from Asp
residues and two of which are provided by water molecules (Nalefski et al. 1996).
5
Figure 1.3. The structure of C2-domain. Anti-parallel p3-sheets are shown in yellow, Ca2 +
binding loops are shown in green, and Ca2+ ions are shown in orange. PDB code 3FO4.
Ca binding to C2-domain triggers protein association to phospholipid membranes and
promotes protein-protein interactions. The proposed mechanism for membrane specific
binding of C2-domain proteins is that the Ca2+ binding increases the exposure of
hydrophobic residues that ultimately leads to the increased affinity of C2-domain
containing proteins for phospholipid membranes and/or other proteins (Scott et al. 1990,
Newton et al. 1995). An alternative mechanism involves the exposure of charged residues
which can interact with phosphate groups of phospholipid membranes through
electrostatic interactions (Newton et al. 1995).
1.3.2. Annexins
Annexins represent a group of proteins that contains a characteristic "annexin repeat"
formed by a 70 residue long segment. In general, four such annexin repeats are found in
annexins. Structurally annexins are composed of two separated domains connected by a
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central core of tightly packed a-helices as shown in Figure 1.4 (Weng et at. 1993). As a
result of a tight packing of the central core, the overall structure of the protein resembles
a disc with a slight curvature forming concave and convex surfaces on the bottom and top
of the protein surface, respectively (Weng et al. 1993). Annexins bind to the phospholipid
membrane in such a way that the concave surface of the protein points away from the
membrane and the convex surface faces towards the membrane (Weng et al. 1993).
Annexin association to phosholipid membranes occurs in a Ca2+ dependent manner. The
Ca2+ binding sites are located on the convex surface. The N-terminal domain is
irregularly structured in the apo-protein and interacts with the central core domain. Upon
Ca2+ binding, the N-terminal domain becomes exposed and promotes annexin
interactions with other proteins such as S 100 proteins (Weng et al. 1993). Annexins have
been shown to be involved in various functions like exocytosis, endocytosis, stabilization
and organization of phospholipid membranes (Rescher et al. 2004).
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Figure 1.4. Structure of annexins (PDB code: 1YII). Tightly packed central helices are
shown in blue and the N- and C-terminal domains are shown in red.
1.3.3. EF-hand motif
Most of the CaBPs contains an EF-hand as the Ca 2+ binding structural motif. The name
EF-hand was originally proposed by Krestinger when this Ca binding motif was first
observed in parvalbumin (Kretsinger et al. 1973). The number of EF-hands usually
ranges from four to six and the majority of proteins carry an even number of EF-hands.
Each EF-hand consists of an entering a-helix and an exiting a-helix bridged by a nine
residue Ca2+ chelation loop with Ca + being coordinated by seven oxygen atoms arranged
in pentagonal bi-pyramidal fashion (Gifford et al. 2007). Five oxygen ligands are
provided by residues in the chelation loop and the remaining two ligands come from the
side chain of the glutamic acid that is located on the exiting helix (Gifford et al. 2007).
The residues involved in Ca2+ binding are shown in Figure 1.5.
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Figure 1.5. Schematic representation of EF-hand showing the name and position of
ligands involved in Ca2+ chelation. (Figure modified from Gifford et al. 2007)
Within the chelation loop, Ca2+ is coordinated through the side chains of four Asp
residues located in position 1, 3, 5 and 8. The 5th ligand is provided by a carbonyl oxygen
from the residue located at 8 th position. All residues involved in chelation interact with
Ca2+ directly except a residue presented in the ninth position of the loop, which
coordinates Ca2+ through a water molecule (Likik et al. 2003, Gifford et al. 2007).
Chelating residues also play a prominent role in the stabilization of the loop by forming a
network of hydrogen bonds with non-chelating residues. In addition the high
conformational flexibility of a glycine residue located in the sixth position allows for a
sharp 90 turn of the loop during Ca2 binding that facilitates the Ca2+ coordination within
the loop (Gifford et al. 2007). The eighth position of the loop is occupied by a conserved
hydrophobic residue whose backbone NH and CO groups are directed away from Ca2+
9
towards the paired EF-hand (Godzik et al. 1989) and facilitates the formation of the anti-
parallel P-sheet through hydrogen bonding with the corresponding NH and CO groups of
the paired EF-hand. Hydrogen bonding between the paired EF-hand loops facilitates
communication between individual EF-hands (Godzik et al. 1989). A cartoon picture of a
single EF-hand is shown in Figure 1.6
Figure 1.6. Cartoon picture of a single EF-hand. Entering helix is shown in purple,
calcium chelation loop is shown in green, exiting helix is shown in blue and the position
of the anti-parallel -sheet is shown in yellow (PDB code QX5).
Apart from the canonical EF-hand described above, other types of EF-hands, called non-
canonical EF-hands, have been reported (Gifford et al. 2007). Non-canonical EF-hands
deviate from the regular EF-hands in terms of the number of residues involved in the
Ca2 1 chelation or in the length of the loop because of the insertion or deletion of residues
10
present in the canonical EF-hand (Haiech et al. 2004, Cook et al. 1993, Vijay et al. 1992).
These non-canonical EF-hands are categorized into four groups. The first group contains
non-canonical EF-hand loops that have a glutamic acid at the 12th position replaced by an
aspartic acid. This substitution decreases selectivity for Ca2+, and the loop preferably
binds Mg 2+ (Cook et al. 1993, Vijay et al. 1992). The second subgroup under non-
canonical EF-hand loops is the pseudo EF-hand loop in which the additional residues are
inserted between the residues in the 1st and 3 rd position. As a result of the residue
insertion, backbone carbonyl oxygens of the residues located at 1st and 3 rd position act as
liganding residues in those pseudo EF-hands, unlike the side chain oxygens as seen in the
case of the canonical EF-hands (Nagae et al. 2003, Hohenestter et al. 1996). Insertion of
one or two residues into the regular canonical EF-hand loop seems to have a
predominantly localized effect, as this type of non-canonical EF-hand shows similar Ca*
binding properties as canonical EF-hands (Hohenester et al. 1996). The third type of non-
canonical EF-hand differs from the regular EF-hand in terms of length of the loop. The
EF-hand in this group contains an eleven residue loop that binds Ca2+ preferably through
backbone carbonyl oxygens and a water molecule (Bianchard et al. 1997). The fourth
type of non-canonical EF-hand contains an insertion of two additional residues in the C-
terminal end of the loop that makes the residue in 12 th position move far away from the
liganding position. Because of such displacement of the bidentate ligand, residues located
in the N-terminal part of the loop coordinate Ca2+ in an octahedral geometry, and this
type of chelation leads to lower affinity for Ca2+ (Jia et al. 2001).
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1.4. EF-hand pair
In the majority of EF-hand proteins, EF-hands always occur in pairs even if one of the
EF-hand is nonfunctional as in the case of Neries diversicolor sarcoplasmic reticulum
Ca binding proteins (Vijay et al. 1992). There are some proteins that contain an odd
number of EF-hands, for example a voltage gated Ca 2+ channel has a single functional
EF-hand (Bunet et al. 2005). Parvalbumin contains three EF-hands but the unpaired EF-
hand is not functional (Babini et al. 2005). The EF-hands, apart from acting as Ca2+
binding sites, are also involved in promoting protein dimerization as seen in case of five
EF-hand containing proteins like calpain, in which the fifth EF-hand gets paired up with a
corresponding single EF-hand presented on the second monomer (Blanchard et al. 1997,
Jia et al. 2001, Ilari et al. 2002, Jia et al. 2000, Reid et al. 1990, Shaw et al. 1990, Shaw et
al. 1992). An example of the organization of an EF-hand pair is shown in Figure 1.7.
Figure 1.7. The organization of two EF-hands as a pair (PDB code: lQX5). The two Ca2+
binding loops (in green) interact through anti-parallel (3-sheets.
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The two EF-hands found in each pair are thought to communicate through an anti-parallel
p-sheet formed by the hydrophobic residues at the eighth position of the loop (Gifford et
al. 2007). Some proteins have EF-hands that do not form the anti-parallel p-sheet but still
occur in pairs. However, such EF-hands have significantly lower affinity for Cat (Cook
et al. 1993). The strong tendency of the EF-hands to exist as a pair is further supported by
several studies on isolated EF-hands of calmodulin (CaM) and troponin C (Reid et al.
1990, Shaw et al. 1990, Shaw et al. 1992). In solution, the isolated EF-hands tend to form
homodimers in a Ca2+ dependent manner. On the other hand, EF-hand homodimers
readily dissociate and form heterodimers in the presence of a complementary EF-hand,
indicating a strong affinity for heterodimers (Raid et al. 1981, Shaw et al. 1991).
1.5. EF-hand domain organization
In general, most of the EF-hand containing proteins contain four EF-hands arranged in
two pairs with one pair in the N-terminal domain and another pair in the C-terminal
domain (Gofford et al. 2007). Although there is certain similarity in structural
organization of CaBP' s, the ability to perform different functions comes from the
diversity in the organization of the domains. On the basis of the structural arrangement of
the individual domains, EF-hand proteins are broadly classified into three groups
(Gofford et al. 2007). The proteins that belong to the first type have their N and C
terminal domains connected by a flexible linker allowing the two domains to orient in
different positions with respect to each other as seen in CaM and troponin C (Gifford et
al. 2007, Babu et al. 1985). The second type of proteins are the neuronal calcium sensors
where the two domains are connected by a "U" shaped linker forming a compact globule-
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like-structure with the two domains facing each other as shown in Figure 1.8 (Ames et al.
2000, Ames et al. 1999). This type of the domain arrangement restricts the movement of
the individual domains. The third type of domain arrangement exhibits a compact
globular structure similar to the neuronal calcium sensor family (NCS) except that the
two domains are arranged opposite each other as seen in inverterbrate sarcoplasmic
reticulum CaBPs (Cook et al. 1993, Vijay et al. 1992). Other proteins like calbindin have
six EF-hands arranged in three pairs and the two domains are arranged in a more compact
fashion in a way similar to that of NCS (Kojetin et al. 2006).
A B
Figure 1.8. Arrangement of Ca' binding domain in CaBPs. A) CaM with a flexible
linker (PDB code: 1EXR). B) Recoverin with a "U" shaped linker (PDB code: 1JSA). In
both proteins, N- and C-terminal domains are shown in violet and blue, respectively, and
the linker is shown in red.
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1.6. Affinity and selectivity of EF-hand loop for calcium
Ca2+ binding affinity of EF-hand loops ranges from the nM to the mM level (Gifford et
al. 2007). It is quite surprising considering that EF-hand binding sites have very similar
structures and coordinate Ca in similar fashions. The differences in Ca2+ affinity may
arise from the differences in their intrinsic binding affinity and/or from the selectivity of
the particular EF-hand to bind Ca2+ over similar cations like Mg 2+ (Gifford et al 2007). In
addition, the cooperativity between the EF-hands nay be a key factor in tuning the Ca2+
binding properties. The affinity of the EF-hand to bind Ca2+ may also be altered by
CaBPs interaction with target proteins (Johnson et al. 1996, Olwin et al. 1984, Olwin et
al. 1985, Persechini et al. 1996, Yazawa et al. 1992, Gifford et al. 2007).
Intrinsic binding affinity depends on the free energy associated with Ca2+ binding as well
as on the difference in the stability of the protein in the apo and Ca2+ bound form. The
change in free energy associated with Ca2+ binding to the EF-hand includes enthalpic and
entropic contributions according to Equation 1 (Gifford et al. 2007)
AG = AH-TAS (1)
where AG is change in the free energy, AH represents the change in enthalpy, T is the
temperature, and AS stands for change in the entropy. Previous studies proposed that
water molecules exist in a "frozen state" in the Ca2+ binding loop and play an important
role in determining the entropic contribution to the affinity of the EF-hand (Gifford et al.
2007). The magnitude of the entropy increase depends on the number of water molecules
exchanged between the loop and the surrounding solvent upon Ca 2+ binding (Gifford et
al. 2007, Drake et al. 1996, Lee et al. 2004). On the other hand, enthalpy changes
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associated with Ca 2+ ions binding to the loop are generally endothermic because of the
high dehydration energies of the Ca2+. However depending on the position and
arrangement of the chelating residues, the overall enthalpy change for Ca2+ can be
exothermic as a result of constructive electrostatic interactions between the negatively
charged chelating residues and the Ca2+ ion (Gifford et al. 2007). A favorable enthalpy
change is usually observed if the repulsion between the liganding residues is minimal in
the Ca2' bound form (Gifford et al. 2007, Reid et al. 1980).
Another important aspect of Ca2+ binding to CaBPs is the selectivity of the EF-hand for
the Ca ion compared to Na+, K+, and Mg 2+ (Falke et al. 1991). The EF-hands have a
very low affinity for Na+ and K+ ions because these cations are not able to completely
shield the negative charge on the EF-hand loop (Falke et al. 1991). More importantly, the
Mg2+ ion concentration in the resting cell is 102 to 10' fold higher than the Ca2+
concentration (Gifford et al. 2007) and all the canonical EF-hands bind Ca2+ with much
higher affinity compared to Mg2+. There are two factors that contribute to this selectivity
for Ca2+ over Mg2+: 1) Mg2+ ion is smaller and thus the energy required to dehydrate the
smaller ion is larger than the energy for Ca2+ ion dehydration. 2) arrangement of the
chelating residues in pentagonal bi- pyramidal fashion in an EF-hand loop is not the
preferred geometry for Mg2+ ion chelation (Martin, et al. 1990). However, in case of non-
canonical EF-hands with high affinity for Mg2+, the Mg2+ ion is coordinated by six
ligands in octahedral geometry because of the rotation of C,-Ca bond of aspartate residue
at the 12th position of the EF-hand loop (Houdusse et al. 1996, Blumenschein et al. 2000).
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Because of this rotation, Asp can act as a monodentate ligand and it reduces the total
number of liganding residues to six (Anderson et al. 1997).
Entropy also contributes to the high selectivity of the Ca2+ specific EF-hand, since
coordination of Mg2+ by canonical EF-hands includes an additional water molecule
(Potter et al. 1975). Other important factor is the cooperativity between the EF-hand
loops forming an EF-hand pair. Positive cooperativity between the EF-hands contributes
to the increase in EF-hand affinity for Ca2+, but cooperative binding was not observed
incase of Mg2+ binding (Linse et al. 1991, Gifford et al. 2007).
1.7. Calmodulin
1.7.1. Functions of calmodulin
Calmodulin is an important intracellular protein that regulates a variety of physiological
processes including smooth muscle contraction, activation of kinases and phosphatases,
energy metabolism and cyclic nucleotide metabolism (Clapham et al. 2007). For
example, regulation of smooth muscle contraction occurs through a reversible
phosphorylation of regulatory light chain myosin by CaM activated myosin light chain
kinase (Meador et al. 1992). CaM is involved in the regulation of activity of various ion
channels like plasma membrane Ca2+ ATPases (PMCAs) (Siegel et al. 1999). Apart from
this, CaM is also participates in the regulation of energy metabolism by controlling the
activity of certain enzymes such as phosphorylase kinase that is a key enzyme in
glycogen metabolism (Cox et al. 1982). Interestingly, CaM is nearly uniformly
distributed throughout the cytoplasm whereas other CaBPs are found to be localized
within the cell, indicating the wide range of CaM functions (Babu et al. 1985).
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1.7.2 Structure of calmodulin
Calmodulin is a 17 kDa protein containing 148 residues with a high degree of a-helical
structure. It has four EF-hands and each domain contains one EF-hand pair (Babu et al.
1985). All four EF-hands are capable of Ca 2+ binding. The amino acid sequence of the
protein along with the residues involved in the formation of EF-hand loops is shown in
Figure 1.9 (Shea et al. 1996).
AEOLTEEQIAEFKEAFALFDIDGDGTITTKELGTVMRSLGONPTEAELODMINEVDADGN
2 10 20 40 5p 6'
- VV VVV\N/\r^--+,VVAr" A
GTIDFPEFLSLMARKMKEQDSEEELIEAFKVFDRDGNGLISAAELRHVMTNLGEKLTDDE
61 70 86 96 10' 11' 120
VDEMI RE AD I DGDGH I NYE E FVRMMVSK
- 121 130 146
Figure 1.9. Amino acid sequence of rat CaM. The amino acid residues involved in the
formation of a-helices are shown in orange, p-sheets in yellow, and EF-hands in purple.
PDB code: 1EXR
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AFigure 1.10. The crystal structure of Ca bound calmodulin. All four Ca binding loops
are shown in green and the Ca2+ cations are shown as orange spheres. All the helices
from A-H are represented with different colors, the p3-sheets are shown in yellow (PDB
code: 1EXR).
The CaM crystal structure shows eight a-helices labelled A-D and E-H that are found in
the N and C-terminal domain respectively, as shown in Figure 1.10. Helices A/B, C/D,
E/F, and G/H form pairs connected by nine residue Ca binding loops forming EF-hands
1, 2, 3, and 4 respectively (Kubinova et al. 1985, Shea et al. 1996). The exiting helix D of
EF-hand loop 2 continues as entering helix E of EF-hand loop 3 found in the C-terminal
domain. The helices D and E together acts as a linker between the two domains and is
often called the "central helix" (Zhang et al. 1995). Such interdomain arrangement gives
the protein a dumbbell structure (Babu et al. 1985). Previous NMR studies on CaM
proposed that the central helix is very flexible and plays a prominent role in the binding
of CaM to the target proteins (Ikura et al. 1992, Meador et al. 1993, Meador et al. 1992).
However, it is still under debate whether the central helix has more a-helical content in
19
the apo form or the Ca2+ bound form (Kubinova et al. 1985). The X-ray structure of CaM
indicated that the central helix has more a-helical content than NMR data does in case of
Ca2+ saturated CaM (Babu et al. 1985, Zhang et al. 1995). The difference probably arised
from the experimental conditions used in X-ray studies that may promote formation of a-
helices. The two pairs of helices found in each domain form a compact globular structure
through extensive hydrophobic interactions. However, helix C from the N-terminal
domain and helix G from the C-terminal domain have few hydrophobic contacts
compared to other helices in their respective domains (Zhang et al. 1995).
1.7.3. Calcium induced conformational changes in calmodulin
The entering and exiting helices of EF-hands are almost anti-parallel to each other in the
Ca2+ free form of CaM. The inter-helical angles in the C-domain are slightly higher than
in the N-domain in the apo form of CaM indicating a smaller degree of hydrophobic
interactions involved in the packing of C-domain (Zhang et al. 1995). It was also shown
that helix A from the N-terminal domain interacts with the residues presented in the
central helix and stabilizes the N-terminal domain in the apo form (Chen et al. 2008).
Differences in the arrangement of the helices in the two domains likely contribute to the
higher Ca2+ binding affinity of the C-terminal domain (Kubinova et al. 1995, Babu et al.
1985, Zhang et al. 1995). Indeed, the affinity of the EF-hand pair at the C-terminal
domain is about 10 times higher (Kd = 1 [M) than the affinity of the EF-hand pair in the
N-terminal domain (K= 10 [M), which is more stable in apo form (Kubinova et al.
1995, Babu et al. 1985, Zhang et al. 1995).
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Binding of Ca2+ to EF-hands leads to the repositioning of the exiting helix to be
perpendicular with respect to the entering helix as shown in Figure 1.11 (Gifford et al.
2007, Zhang et al. 1995). This helical movement brings the bidentate ligand at the 12th
position close to the Ca in the liganding position.
D.
D C
A
A C B
B
B
Figure 1.11. The relative orientation of a-helices in the apo form (left) and Ca2+ bound
form (right) of CaM. In the apo form, the entering and exiting helices are nearly anti-
parallel to each other whereas in the Ca2+ bound form they are perpendicular to each
other (PDB code: 1QX5, 1EXR)
Calcium induced repositioning of a-helices leads to increase of the distance and the angle
between the EF-hand helices, causes loss of interhelical hydrophobic contacts and
promotes an opening of both domains which is termed "close-to-open domain transition".
Similar changes in the helical angles were observed in troponin C and in neuronal Ca 2 +
sensor recoverin indicating that the change in helical angles is a common conformational
change that occurs in majority of the Ca 2+ regulatory proteins (Herzberg et al. 1988,
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Zhang et al. 1995). When CaM is in the apo form, the repulsion between the negative
charges of the liganding residues makes the EF-hand loops more flexible compared to
Ca2+ bound form which might be one of the reasons why the crystal structure of apo CaM
has not yet been determined (Zhang et al. 1995, Babu et al. 1985).
Exposure of the hydrophobic patches on N- and C-terminal domain of CaM is the other
major change that occurs in the CaM upon Ca2+ binding. The exposed hydrophobic
patches contain a central hydrophobic groove surrounded by negatively charged residues
(Meador et al. 1993, Meador et al. 1992). Exposure of hydrophobic patches is likely to be
important step of CaM activation since, CaM interactions with target proteins occur
predominantly through hydrophobic interactions (Ikura et al. 1986, Meador et at. 1993,
Meador et al. 1992). However, the mechanism of CaM activation of target proteins is
more complex. In some cases, CaM binds to target proteins even in the absence of Ca2 +
as seen in the case of neuromodulin (Apel et al. 1992). CaM ability to activate target
proteins in apo form was attributed to the fact that hydrophobic residues are partially
surface exposed in the apo form of CaM (Apel et al. 1992). Structural studies have shown
that several methionine residues are located in hydrophobic patches. Four out of the nine
methionine residues found in C are presented in the N- and C-terminal domain and
one methionine is located in the central helix (Babu et al. 1988). Shielding of methionine
residues from the solvent in the apo CaM and their exposure upon Ca2+ binding suggests
that methionine residues play an important role in the interaction of CaM with target
proteins (Zhang et al. 1995, 0' Niel et al. 1988).
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The detailed sequence of conformational changes that occur upon Ca2 binding to CaM
was proposed recently by Chen et al. (2008). As a result of Ca2+ binding to the C-terminal
domain, rearrangement of helices occurs and facilitates the formation of a hydrogen bond
between Tyr 138 found in the EF-hand 4 and Glu 82 that is situated in the central helix
(Chen et al. 2008). In the apo form, helix A stabilizes the N-terminal binding site by
forming extensive contacts with the central helix (Faga et al. 2003). However, formation
of the hydrogen bond between the Tyr 138 and Glu 82 and the reorganization of the
helices in the C-terminal domain, promotes the formation of more organized helical
structure in the helix A. As a result, helix A is detached from the central a-helix leading
to the destabilization of the N-terminal domain. The instability promotes Ca2+ binding to
the N-terminal EF-hands, and subsequent reaarangement of the a-helices in N-terminal
domain. All these sequential changes that occur upon Ca2+ binding subsequently leads to
the exposure of hydrophobic patch through which calmodulin interacts with a wide
variety of targets (Chen et al. 2008).
1.8. Neuronal calcium sensors
Neuronal calcium sensors (NCS) represent a new family of Ca2+ binding proteins that
were first described by Nef et al. (Nef et al. 1996). The expression of the NCS family of
proteins is primarily limited to neuronal cells (Chin et al. 2000, Burgoyne et al. 2001,
Burgoyne et al. 2007). Such localization to a specific type of cells indicates that NCS
proteins participate in the regulation of specific functions. In the human genome, NCS
family of proteins are encoded by 14 genes and show a large diversity in their functions
as a result of the existence of the splice variants (Burgoyne et al. 2004). Current studies
show that NCS are involved in numerous functions like nucleotide metabolism, gene
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expression, modulation of activity of ion channels, regulation of gene expression, etc.
(Braunwell et al. 1999). Neuronal calcium sensors are broadly divided into five sub
classes (A-E) based on their sequence similarity, expression pattern and functions as
shown in Table 1.1. (Burgoyne et al. 2001).
Table 1.1. Classification of NCS family of proteins
Class Name of the subfamily First appearance
A Frequenins (NCS-1) Yeast
B VILIPS Nematodes
C Recoverins Amphibians
D GCAPs Amphibians
E KChIPs Mammals
Vision like proteins (VILIPS) subfamily includes VILIP-1, VILIP-2, VILIP-3,
neurocalcins and hippocalcin (Nef et al. 1996, Braunewell et al. 1999). The GCAPs
(GCAP 1-8) are the guanylate cyclase activating proteins and KChIPs (KChIPs 1-5) are
the potassium channel interacting proteins. Frequenins, also called NCS-1, are the first
NCS members to be identified as neuronal Ca' sensors. NCS-1 was initially found in
yeast (Saccharomyces cerevisiae) and its sequence shares about 59 % identity with its
human analog frequenin (Burgoyne et al. 2001). Frequenins are primarily expressed in
neuronal and kidney cells and are involved in a wide variety of processes such as
neurotransmission, regulation of activity of calcium and potassium channels and most
importantly in controlling short term synaptic plasticity (Slippy et al. 2003, Guo et al.
2002, Nakamura et al. 2001).
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VILIPS are primarily expressed in brain cells of mammals, and are involved in the
activation of guanylyl cyclase and regulation of the activity of PIQ type Ca channels
(Lautermilch et al. 2005). Guanylate cyclase activating proteins and recoverin belong to
the class C and D, respectively, and modulate the activity of retinal guanylyl cyclase
found in retinal cells (Makino et al. 2004, Sampath et al. 2005, Pennesi et al. 2003). The
last subfamily of the NCS are the potassium channel interacting proteins which are
widely expressed in the brain and also in heart tissues. Recent studies confirmed that
KChIP's interact with potassium channels in the absence of Ca2+ and modulate the
channel activity in a Ca dependent manner (Braunwell et al. 1999). Potassium channel
interacting proteins were also associated with assisting of potassium channels trafficking
from Golgi complex to the plasma membranes (Burgoyne et al. 2001, Pioletti et al. 2006).
Neuronal calcium sensors belong to the EF-hand super family and contain four EF-hands,
with the first EF-hand, being non-functional due to the insertion of two extra residues,
cysteine, and proline, in the Ca2+ binding loop (Schaad et al. 1996). Proteins that belong
to the recoverin sub family have non functional EF-hand 4 in addition to EF-hand 1
(Schaad et al. 1996, Burgoyne et al. 2001, Ames et al. 1997).
The sequence similarity between the CaM and NCS members is less than 25% (Burgoyne
et al. 2007). Structural studies have shown that NCS members have a compact globular
structure, unlike CaM which has a dumbbell shaped structure (Burgoyne et al. 2007). All
members of NCS family are N-terminally acylated, very often with myristoyl group.
except the B class members (An et al. 2000, Burgoyne et al. 2007). According to the
initially proposed mechanism of Ca2+ signaling by NCS, the myristoyl group is buried in
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the hydrophobic pocket and the apo protein is localized in cytosol. As a result of Ca2+
induced conformational changes, the myristoyl group becomes solvent exposed thereby
allowing the NCS members to associate to membranes (Burgoyne et al. 2007). However,
such Ca2+ induced repositioning of the myristoyl group does not represent a general
mechanism of Ca2+ transduction in NCS proteins, since the members of the NCS-1 family
were shown to associated to the plasma membrane and Golgi complex in the absence of
Ca2+ (Burgoyne et al. 2001). In case of GCAP 2, myristoyl group is a solvent exposed in
the apo state and was found to be buried inside a hydrophobic pocket upon Ca2+ binding
indicating that Ca association to this protein triggers GCAP dissociation from
phospholipid membranes (Burgoyne et al. 2001)
1.9. Recoverin as a prototype neuronal calcium signaling protein
Recoverin is the first member of the NCS family to be crystallized and its structure is
known in the apo and Ca2+ bound form (Schaad et al 1996). In neuronal cells at high Ca2+
concentrations, recoverin prevents the deactivation of rhodopsin by interacting with
rhdopsin kinase thereby increasing the lifetime of the photoexcited rhodopsin (Sanada et
al. 1996, Braunwell et al. 1999).
The crystal structure of recoverin in apo and Ca2+ bound forms are shown in Figure 1.12.
The N and C-terminal domains are linked by a "U" shaped linker. Only EF-hand 2 and
EF-hand 3 bind Ca2+ with a high affinity (Kd = 1 [M). Recoverin as other NCS,
undergoes N-terminal acetylation by myristic acid and this modification is essential for
its Ca2+ dependent association to the phospholipid membranes (Burgoyne et al. 2007). In
the apo form, the myristoyl group is packed in a hydrophobic cavity formed by residues
26
from EF-hand 2, 3 and 4 (Burgoyne et al. 2001). Structural studies show that upon Ca2+
binding a conformational switch leads to the exposure of the myristoyl group and
exposure of hydrophobic surface through the the rotation of N-terminal domain by about
450 with respect to C-terminal domain (Ames et al. 1997, Burgoyne et al. 2001).. The
repositioning of the myristoyl group upon Ca 2+ binding to recoverin is facilitated by the
glycine residues presented at the 42"d and 96th position (Ames et al. 1997). Exposure of
the myristoyl group to the solvent facilitates association of recoverin to the phospholipid
membranes (Ames et al. 1997).
Figure 1.12. Structure of recoverin in apo (left) and Ca2+ bound form (right). Ca2+ ions
are shown as pink spheres. In apo form the myristoyl group (shown as red spheres) is
sequestered in a hydrophobic cavity whereas upon Ca2+ binding the myristoyl group is
exposed to the solvent (PDB code: IIKU, 1JSA).
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1.10. DREAM (Down Stream Regulatory Element Antagonist Modulator)
1.10.1. Functions of DREAM
The NCS family member DREAM, also known as calsenilin or KChIP 3 is a 29 kDa
protein that is involved in the regulation of cellular processes ranging from regulation of
transcription of genes to modulation of activity of Kv 4 ion channels (Craig et al. 2002). In
the nucleus, DREAM binds to DRE elements on the DNA and regulates the transcription
of prodynorphin and c-fos genes (Carrion et al. 2001). Upon Ca binding DREAM
dissociates from DNA as a result of induced conformational changes. A schematic
representation of DREAM interaction with DNA is shown in the Figure 1.13 (Mellstrom
et al. 2001). The importance of the DREAM as a transcriptional regulator was confirmed
by the studies on DREAM knockout mice which exhibited ongoing analgesia because of
the over expression of prodynorphin (Cheng et al. 2002). Calsenilin was also found to be
involved in the transcriptional regulation of the apoptotic gene hrk by binding to the DRE
sequence present in its 3' untranslated region in a Ca2+ dependent manner (Sanz et al.
2001). In addition to binding to DRE elements, DREAM is found to interact with
hormone receptor elements and regulate the transcription of vitamin D and retinoic acid
receptors (Scsucova et al. 2005). Calsenilin acts as transcriptional activator in a Ca 2
dependent manner by interacting with transcription factors like CREB and CREM (Ledo
et al. 2002, Ledo et al. 2000).
In cytoplasm of eukaryotic cells DREAM interacts with the C-terminal residues of
presinilin 1 and presenilin 2 in the vicinity of endoplasmic reticulum and Golgi apparatus.
Presenilins are a part of gamma secretase that are involved in the production of As
proteins that were associated with Alzheimer's disease (Craig et al. 2000, Coughlan et al.
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2000). Down stream Regulatory Antagonist Modulator (DREAM) was also found to
induce apoptosis by altering the Ca2+ homeostasis within the cell in the presence of
apoptotic triggers like thapsigargin (Lilliehook et aL 2002).
Down stream Regulatory Antagonist Modulator (DREAM) forms an intrinsic subunit of
the Kv 4 potassium channels located in the heart and brain cells and modulates their
activity (Burgoyne et al. 2007, Carrion et al. 1999, Mellstrom et al. 2001).The binding of
the DREAM to the Kv4 potassium channels was shown to be Ca2+ independent. However,
the modulation of the channel activity is Ca2+ dependent (Burgoyne et al. 2001). KChIP 3
is also involved in the trafficking of Kv 4 potassium channels to the plasma membrane
(Burgoyne et al. 2004). Previous studies have shown that in the absence of KChIP 3, Kv4
potassium channels are retained on the Golgi complex and are unable to diffuse to the
plasma membrane (O'Callaghan et al. 2003). However, deletion of 40 residues at the N-
terminal domain allows KV4 association to the plasma membrane. On the basis of these
studies it was proposed that, KV4 channel trafficking to the membranes involves masking
of the N-terminal residues of the potassium channels (O'Callaghan et al. 2003, Burgoyne
et al. 2004).
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Figure 1.13. Schematic model for the mechanism of DREAM interactions with DNA. In
the apo form DREAM binds to DNA as a tetramer and upon Ca2 + binding DREAM
dissociates from DNA and undergoes dimerization.
1.10.2. DREAM Structure
Down stream Regulatory Antagonist Modulator (DREAM) is a 256 amino acid residue
protein with predominantly a-helical structure as shown in Figure 1.14 (Lustin et al.
2008). The NMR structure of DREAM-C shows a compact globular structure similar to
recoverin and other KChIP's with ten a-helices and four $ sheets (Lusin et al. 2008). The
N and C-terminal domain face each other and are connected by a "U" shaped linker
(Lusin et al. 2008). DREAM-C is a deletion mutant of full length DREAM lacking the
first 64 residues (Osawa et al. 2001, Osawa et al. 2005).
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Figure 1.14. NMR structure of DREAM. N-terminal helices of Ca2+ binding loops are
shown in green and the C-terminal helices are shown in brown. Ca2+ ions are shown as
yellow spheres (PDB code 2JUL).
Down stream Regulatory Antagonist Modulator (DREAM) has four EF-hands arranged
as a pair in each domain. Only three EF-hands bind Ca2+ with a high affinity. The EF-
hand 1 is non functional because of the presence of a cysteine-proline insertion in the
Ca binding loop (Osawa et al. 2005). The presence of proline produces a kink in the
Ca2+ binding loop thereby causing the liganding residues to deviate from their chelating
positions (Burgoyne et al. 2001, Lusin et al. 2008). The amino acid sequence and the
residues involved in forming the EF-hand are shown in Figure 1.15.
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Figure 1.15. Amino acid sequence of DREAM. The amino acid residues involved in the
formation of a-helices are shown in orange, (3-sheets in yellow, and EF-hands in purple
(PDB code 2JUL).
The EF-hand 2 has a higher affinity for Mg2+ (Kd=13 [,M) than for Ca2+ because of the
presence of Asp in the 12th position of the loop and EF-hands 3 and 4 have a high affinity
for Ca2+ and their Kd is about 1 iiM (Osawa et al. 2001). Apo-DREAM exists as a
tetramer and binds to DNA (Osawa et al. 2005). The role of Mg2+ binding to EF-hand 2
remains unclear. However, Mg2+ binding to EF-hand 2 was proposed to be necessary for
its sequence specific binding to DRE elements on DNA (Osawa et al. 2001). On the
other hand, in the absence of DNA, binding of Mg2+ to DREAM is likely to stabilize the
protein in monomeric form as proposed by Osawa et al. (Osawa et al. 2005). Previous
studies have also found that four DRE molecules bind to the DREAM tetramer. Among
the four DRE molecules, one molecule binds with a higher affinity (Kd = 75 nM)
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compared to the other three molecules (Ka = 740 nM) (Osawa et al. 2001). Calcium
binding to apo DREAM induces conformational changes that lead to the dissociation of
tetramer into two dimers in the concentrations below 150 tM. In the concentrations range
above 200 pM, DREAM exists as a tetramer irrespective of the presence or absence of
Ca2+ (Osawa et al. 2005). The Kd for the change in oligomnerization state of the DREAM
from tetramer to dimer was reported to be -500 nM (Lusin et al. 2008). Metal ions (Ca 2+,
Mg2+) bound DREAM has more organized and compact structure compared to the apo-
DREAM (Craig et al. 2002). The interactions between the N- and C- terminal domain are
facilitated by the hydrophobic residues exposed on the surface of the EF-hand 2 and EF-
hand 3. The residues that contribute to these domain-domain interactions are Y130, F133,
L134 and A137 from EF-hand 2 and L173, 1190, M197 from EF-hand 3 (Lusin et al.
2008).
Other hydrophobic residues L155, L158, L159, and L251 are well conserved among the
members of the NCS family (Lustin et al. 2008). The exposed N-terminal hydrophobic
residues L155, L158 and L159 are thought to be involved in the dimer formation by
interactions with L251 at the C-terminal domain in a head to tail orientation (Lustin et al.
2008) as shown in Figure 1.16. Similar LxxLL motif was found to be involved in a target
binding as seen in case of transcriptional cofactor proteins that binds to hormone
activated nuclear receptor (Heery et at. 1997, Nolte et al. 1998, Shiau et ale 1998). Apart
from the conserved residues, there is a solvent exposed hydrophobic patch found on the
DREAM surface consisting of residues F100, F114, 1117, Y118, F121, F122, Y151
(Lustin et al. 2008) as shown in Figure 1.17 (Left panel). On the opposite surface of the
33
exposed hydrophobic patch there are a number of charged residues (K87, K90, K91, K98,
K101, R160 and K166) that are not found among other members of this family like
recoverin and may be important for DNA-DREAM interactions (Lustin et al. 2008) as
shown in Figure 1.17 (Right panel).
L251
L155+
L159
L159
L155
L251
Figure 1.16. Ribbon presentation of the NMR structure of DREAM. Residues proposed
to be involved in dimer formation are shown in magenta, Ca2+ ions are shown as orange
spheres (PDB code 2JUL).
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Figure 1.17. Space filling representation of DREAM showing the exposed hydrophobic
patch (left panel) and charged residues (right panel) in green (PDB code 2JUL).
1.10.3. Calcium and magnesium induced conformational changes
The conformational changes that occur upon Ca binding to DREAM are in terms of
change in oligomerization state of DREAM (Osawa et al. 2001). Binding of Mg2+ and
Ca 2+ decreases the DREAM structural flexibility as seen in NMR and mass spectroscopic
studies (Craig et al. 2002, Lusin et al. 2008). DREAM association to DNA may be
facilitated through interactions between charged residues situated on the protein surface
(Figure 1.17) or by forming a coordinate bond between Mg2+ and phosphoryl oxygens
from DNA as seen in case of many other DNA binding proteins (Osawa et al. 2003).
Based on the NMR structure of the Ca 2+ bound form of DREAM it was proposed that
Ca2+ binding may lead to exposure of the hydrophobic residues L155, L158, L159 from
the N-terminal domain and L251 from the C-terminal domain that are believed to
35
participate in the dimer formation. The exposed hydrophobic residues at the dimer
interface might block the charged residues (K87, K90, K91, K98, K101, R160 and
K166), that are thought to be involved in DNA binding. (Lusin et al. 2008, Osawa et al.
2003)
M222
L 167
L218 C239 -
. L170
L191 -f
L194
Figure 1.18. NMR structure of DREAM showing the interaction between C-terminal
helix and the residues from EF-hand 3 and EF-hand 4. C-terminal helix is shown in
yellow, residues from EF-hand 3 are shown in magenta and residues from EF-hand 4 are
shown in blue (PDB code 2JUL).
According to an alternative mechanism, the C-terminal helix (243-254) forms
hydrophobic contacts with the residues presented in EF-hand 3 (L167, A170, M191 and
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L194) and EF-hand 4 (F218, M222 and C239) as shown in Figure 1.18 (Lusin et al.
2008). Upon Ca2+ binding, the C-terminal helix (residues 243-254) that may interact with
EF-hand 3 and 4 in the apo form is likely to be displaced and form hydrophobic contacts
with EF-hand 2. The interactions between EF-hand 2 and the C-terminal helix may
disrupt the Mg2+ interaction with DNA and thereby promote the DREAM dissociation
from DRE sequence (Osawa et al. 2003).
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2.0. Caged Compounds
2,1. Introduction
Caged compounds are photolabile derivatives of the bioactive molecules of interest that
allow for a spatial and temporal control of the bioactive molecule concentration. In a
caged compound a bioactive molecule is trapped in an inactive form until the caged
compound is irradiated (McCray et al. 1989). The bioactive molecule is then released
from the cage what leads to an increase of its solution concentration. A photorelease of
caged molecule offers several advantages in terms of targeted release of caged bioactive
molecule to initiate the biochemical processes. For example, in kinetic studies of ligand
receptor interactions using traditional techniques, delays because of ligand diffusion has
been a major problem (Mayer et al. 2006). Using caged compounds the molecule of
interest can be caged and photocleaved close to the receptor, limiting the delay as a result
of diffusion (Mayer et al. 2006). Caging of molecule of interest may also increase its
membrane permeability as seen in case of adenosine 3',5'-cyclic monophosphate
(Giovannardi et al. 1998). Caged compounds also offer an effective way to protect
bioactive molecules from metabolic transformation as reported for caged ionositol
triphosphate (Nerbonne et al. 2000). As a result, several compounds ranging from protons
to small peptides and proteins have been caged including Ca2 +, DNA, mRNA,
nucleotides, ATP, IP3, enzymes, fluorescent compound like fluorescein, neurotransmitters
like glutamine, GABA, glycine, aspartic acid, serotonin, and dopamine have been caged
(Mayer et al. 2006, Pelliccioli et al. 2002)
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Several conditions have to be fulfilled for successful application of caged compounds.
The caged compound as well as its photoproducts should be soluble in aqueous solutions.
Photoproducts must have very low affinity for the released bioactive molecule and should
be biologically inert. Caged compounds should have a high absorptivity above 300 nm to
prevent the concomitant excitation of other biological species (Givens et al. 2003). The
release rate of the caged bioactive molecule should be faster than the kinetics to be
studied. The photochemical quantum yield should be reasonably high i.e., at least larger
than 0.1 for efficient release of the caged molecule. Finally the synthetic procedure of a
caged compound should be relatively simple with a high yield (Pelliccioli et al. 2002).
Caged compounds have been successfully used in several studies. For example, caged
Ca compounds like DM-nitrophen and NP-EGTA are widely used to regulate various
processes controlled by the change in Ca2+ concentration (Adams et al. 1988). An
important application is the study of the impact of membrane depolarization on
neurotransmitter release. Ca2+ release from ion channels was blocked using
pharmacological agents and the Calcium concentration was raised by uncaging the caged
Ca2+ compound thereby causing membrane depolarization. These results showed that
membrane potential has no direct role in the neurotransmitter release (Zucker et al. 1988).
An alternative pathway for the study of processes activated by Ca2+ is by using caged
secondary messengers like inositol triphosphate to trigger the intracellular release of the
Ca (Pelliccioli et al. 2002). For example 4, 5-dimethoxy-2-nitrobenzyl ether have been
successfully used as ionositol triphosphate cage for the release of Ca2+ in the gene
expression studies (Li et al. 1998). The other major area of caged compounds application
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is to study fast protein folding reactions since these reactions occur on ns to ps time scale
and was successfully used in case of a small peptide villin headpiece showing that coil-
helix transition occurs on the 400 ns time scale (Eaton et al. 2000, Hansen et al. 2000).
Several caged peptides have been synthesized and used to inhibit activity of target
proteins. For example, caged peptides have been used to study the role of Ca' bound
CaM complex with myosin in the movement of leukocytes using RS-20 cage, a target
peptide for CaM binding (Walker et al. 1998, Tatsu et al. 1996).
Fluorescent probes such as fluorescein, resofurin, and rhodamines have been also caged
in such a way that caged fluorophores become fluorescent upon irradiation (Jasuja et al.
1999). Caged fluorophores have been applied for visualization and tracking of cellular
components (Speccht et al. 2009). Other applications include quantification of the
photoreleased substrates. For example caged 8-hydroxypyrene-1, 3, 6-trisulfonic acid was
used to quantify the amount of aspartate released from a caged L-aspartate (Jasuja et al.
1999). Other promising area is an application of caged compounds or caged proteins to
photo-trigger biological events is the time resolved X-ray studies (Srajer et al. 1996,
Specht et al. 2001). Caged DNA can also be used to control the gene expression by the
plasmid photo-protection. This approach was found to be successful in the suppression of
luciferase expression in rat skin cells (Monroe et al. 1999).
2.2. Mechanism of photo-dissociation of o-nitrobenzyl compounds
There are several types of protecting groups available, such as o-nitrobenzyl (2-
nitrobenzyl), o-alkylated aryl ketones, benzoin group, p-hydroxyphenacyl group, o-
substituted methyl phenols, and coumarinyl group (Pelliccioli et al. 2002). Among them
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2-nitrobenzyl group based cages are often used because of their ability to be covalently
attached to a wide variety of functional moieties like amines, phosphates, carboxylic
acids, alcohols, and nucleotides (McCray et al. 1989). Apart from their ability to carry a
variety of substrates, o-nitrobenzyl cages provide several advantages in term of high
quantum yield and relatively fast photorelease of caged compound (Nerbonne et al. 1986,
Gurney et al. 1987, Kaplan et aL. 1993).
The reaction mechanism for the photorelease of the protected moiety from 2-nitrobenzyl
compounds have been previously studied using determined R, time-resolved absorption
spectroscopy and computational methods (Cheng et al. 2002, Gaplovsky et al. 2005,
Corrie et al. 2003, Schworer et al. 2001, Ill'ichev et al. 2004). The mechanism is shown
in Scheme 2.
R R R R
X hv H+ +H+
1-5 + 4--- -+
NO2  N-OH +H+ NO -H+ N-O
a b b'O b OH
I
R R ROH X
x+ H+-+ X- 
/
N O 02 N
d c OH
Scheme 2:
The initial step in the reaction mechanism is the rapid transfer of a proton from benzylic
carbon to the nitro group forming an aci-nitro anion b' which has a characteristic
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absorption spectrum between 400-440 nm. The aci-nitro anion is found to be in the
equilibrium with its protonated form b and decays to form a cyclic benzisoxazolidine c.
The benzisoxazolidine than decays into a hemiacetal intermediate d that subsequently
undergoes a hydrolysis to form a 2-nitroso benzaldehyde product e by releasing the caged
species X. The decay of the aci-nitro anion can be easily monitored by time resolved
absorption spectroscopy by following the absorption change in the range between 400-
440 nm (Wieboldt et al. 2002). Previous studies indicated that the decay of aci-nitro
intermediate depends on the type of cage and as well as the nature of leaving group
(Corrie et al. 2005, Schwore et al. 2001, Il'Ichev et al. 2004). For example, the release of
the proton from nitrobenzaldehyde occurs on a nanosecond time scale whereas the release
of alcohol group from caged alcohols happens on the millisecond time scales
(Abbruzzetti et aL 2003, George et al. 1980, Morrison et al. 1965). It was shown that the
rate constant for each step in the reaction mechanism depends on the pH, solvent, and the
nature of the leaving group (Corrie et al. 2003, Schworer et al. 2001, Ill'ichev et al.
2004). For example, in case of caged ATP, the aci-nitro intermediates decays with the
rate constant of 86 s- with conco mtant release of ATP. On the other hand, methanol
release from 2-nitrobenzyl methyl ethers occurs with the rate of 2.5 x 102 s-1 that is
significantly slower than the decay of aci-nitro intermediates (Ill'ichev et al. 2004). In
case of DM-nitrophen the decay of aci-nitro intermediates is found to be biphasic with a
rate constant of 8.0 x 103 s-1 and 11 x 103 s-1 (Ayer et al. 1999).
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2.3. Caged calcium compounds
Among the caged compounds, Ca2+ cages are widely used in various physiological
studies. A number of Ca2+ cages have been developed with either EDTA or EGTA as
their parent chelators. Among them, DM-nitrophen, nitr-5, NP-EGTA are important
cages whose affinity for Ca2+ changes more than 1000 times upon photolysis (Ellis-Davis
et al. 2008). Nitro-phenyl-EGTA has a higher selectivity for Ca2+ than for Mg 2+.
However, it is not widely used as its affinity for Ca2+ is highly pH dependent (Adams et
al. 1988). The other disadvantage of using NP-EGTA is its relatively high Ka compared
to DM-nitrophen which is about 80 nM (Nerbonne et al. 1996). The Ka value of NP-
EGTA indicates that only 50 % of the chelator is saturated at the physiological Ca2+
concentrations (100 nM) and hence a fraction of Ca2+ released upon photolysis rebinds to
the free unphotolysed chelator, instead of binding to the target proteins. On the other
hand, DM-nitrophen has a very low Kd of about 4 nM and thus DM-nitrophen is
completely saturated at the physiological Ca2+ concentrations. The main disadvantage of
using DM-nitrophen is that it is not highly selective for Ca2+ (Nerbonne et al. 1996).
Apart from NP-EGTA and DM-nitrophen, which are widely used and commercially
available, other Ca2+ cages were synthesized and characterized including nitr-5, nitr-7,
DMNPE-4, nitr-2, NDBF-EGTA (Ellis-Davies et al. 2008). The usage of nitr-5, nitr-7,
and nitr-2 is limited because of their high Ka which is in the range of 100 nM and the
affinity of photoproducts for Ca2+ is only about 40 times lower compared to the
unphotolysed cage (Hassoni et al. 1994, Van-Koeveringe et al. 1994). General properties
of commonly used Ca cages are summarized in the Table 2.1 (Ellis-Davis et al. 2008)
and the structure of DM-nitrophen, NP-EGTA and nitr-2 is shown in Figure 2.1. Unlike
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other caged compounds, affinity of diazo-2 for Ca2+ increases about 30-40 times upon
photolysis i.e. it has a Kd about 2.2 M before illumination whereas photoproducts
formed has a significantly lower K- ~ 80 nM (Adams et al. 1993). This compound has
been successfully used in studies of muscle relaxation (Ashley et al. 1991).
Table 2.1. Properties of the commonly available caged Ca2+compounds.
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Figure 2.1. Structures of commonly used o-nirobenzyl Ca" cages.
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3.0. Aim of the study
3.1. Specific Aim 1
To construct the thermodynamic profile associated with photorelease of Ca2+ from DM-
nitrophen and its binding to CaM.
Previous studies on Ca' binding to CaM have showed that upon Ca ' binding a
hydrophobic patch is exposed on the protein surface as a result of Ca2+ induced
conformational changes, thereby enabling the protein to activate target proteins. To date,
the majority of the biochemical and biophysical studies have been focused on
understanding the equilibrium properties of the apo and Ca2' bound forms of CaM,
including Ca2 and Mg2 affinity constants, the structure of the apo and Ca2+ bound CaM
and Ca2 induced conformational changes. It was also proposed that Ca2' binding to CaM
is a two step reaction which includes Ca binding to the C-terminal domain followed by
binding to the N-terminal domain (Gifford et aL. 2007). Significantly less is known about
the kinetics of Ca binding and time-resolved energetics of conformational changes
associated with Ca binding to calmodulin, Recent studies by Parker et al. (2008) and
Tjandra et al. (1995) showed that the kinetics of conformational changes induced by Ca2
binding to the C-terminal domain occur with a t - 490 [,s whereas to the N-terminal
domain is slower with i - 20 ms. Since CaM possesses a single internal fluorophore,
tyrosine, the number of spectroscopic techniques that can be used to monitor the time
profiles of Ca> induced conformational changes in this protein is limited. More
importantly, mixing techniques like stopped-flow, probe kinetics occurr on a longer time
scale (>1 is) and thus do not provide information about structural changes occurring on
sub-millisecond time scales. Hence, I took advantage of caged Ca> compound DM-
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nitrophen in combination with photothermal beam deflection to determine the volume
and enthalpy changes associated with Ca2+ binding to CaM. Since the overall volume and
enthalpy changes are determined in photothermal measurements this approach allows one
to evaluate conformational changes in the absence of intrinsic or extrinsic fluorophore.
The proposed model for Ca 2+ binding to CaM is shown in Scheme 3.
Ca2+-DM-nitrophen + apo-CaM - > (Ca 2+)2 - CaM + (DM-nitrophen)PP (Ca 2+)4 - CaM
Scheme 3:
According to this model , photolysis of Ca 2-DM-nitrophen leads to Ca2+ released into
the solution and then Ca2+ preferentially binds to CaM, as the affinity of the DM-
nitrophen photoproducts (DM-nitrophenpp) for Ca2+ is smaller than that of CaM. Initially,
the released Ca2+ binds to the C-terminal domain forming (Ca2+)2-CaM, and reaction is
completed upon Ca2+ binding to the N-terminal domain forming (Ca2+)4-CaM. Though
measurements of the volume changes in proteins are relatively unusual they provide
valuable information in terms of quantification of ligand induced conformational
changes, since the volume change represents the overall change in the molecular
structure. As DM-nitrophen forms part of our sample along with the protein, as shown in
Scheme 3, the thermodynamic parameters for the photodissociation of DM-nitrophen,
DM-nitrophen saturated with Ca2+ and DM-nitrophen saturated with g2+ were also
determined. The data obtained from specific aim 1 provide information about the kinetics
as well as the energetics associated with Ca 2+ induced conformational changes in CaM.
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3.2 Specific Aim 2
To probe the conformational dynamics coupled with Ca2+/ Mg 2+ binding to DREAM.
Down stream Regulatory Antagonist Modulator (DREAM) is a member of a newly
discovered NCS family that is found predominantly in neuronal cells. The fact that
DREAM directly regulates expression of numerous genes in Ca2+ dependent manner,
makes it a unique model for understanding the mechanism of EF-hand proteins
interaction with DNA. However, little is known about Ca /Mg2+ interaction with
DREAM mainly because of the absence of the 3D structure of apo and DNA bound
protein. Also, the kinetic data on Ca2+ interactions with DREAM are scarce. With this in
mind, I isolated and purified DREAM-C and investigated structural changes associated
with Ca /Mg2+ binding to DREAM using steady-state and time-resolved fluorescence
spectroscopic techniques. I hypothesize that the ligand induced alteration in the DREAM
equilibrium dynamics leads to the change in the affinity between individual DREAM
monomers. The present study will take advantage of a single tryptophan residue 169,
found in the sequence of DREAM. Tryptophan 169 is a part of the conserved
hydrophobic surface located between the EF-hands 2 and 3. Thus, monitoring the
fluorescence properties of Trp residue will allow one to probe conformational changes
within the interface of the C and N-terminal domain of DREAM. Moreover Ca2+ induced
changes in the hydrophobic surface of DREAM will be probed using fluorophores 2,6-
ANS, 1,8-ANS and nile red that selectively bind to hydrophobic surfaces on protein.
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4.0. Materials and Methods
4.1. Isolation of calmodulin
Calmodulin was isolated and purified according to the procedure described previously by
Hayashi et al. 1998. F. coli (BL21) containing CaM plasmid (donated by Dr. J. P. Davis,
Ohio State University) was grown on LB agar medium (15 g of agar per one litre of LB
medium) with 100 pg mE1 of ampicillin for 12-14 hours at 37 *C. The composition of
LB medium is shown in Table 4.1. Single colonies were isolated and used to inoculate
one litre of LB medium containing 100 g ml- of ampicillin.
Table 4.1. Composition of LB medium per liter
Component Amount (g)/L
Tryptone 10
Yeast extract 5
NaCl 10
pH = 7.0
Upon inoculation, cells were grown at 37 "C and 250 rpm (Maxe 4000, Bamstead
International) until the absorbance reached an O.D. between 0.6-0.8 at 600 nm.
Subsequently, CaM expression was induced by adding 0.4 rnM isopropyl p-D-l
galactothiopyranoside (IPTG), and the cells were grown for an additional 3-4 hours. Cells
were then harvested by centrifugation for 15 minutes at 8000 rpm at 10 C (Allegra M
64R centrifuge, Beckran Coulter). Collected cells were resusupended in 35 mL of
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resuspension buffer per one litre of the LB medium used. The composition of the
resusupension buffer was 50 mM Tris, pH = 7.5, 1 mM DTT, 1 mM PMSF, 2 mM
EDTA. Resusupended cells were placed on ice and sonicated using a sonic dismembrator
(Fischer Scientific, Model 100) for 30 x 30 seconds with a maximum output of 10. The
solution was centrifuged at 11000 rpm for 30 minutes (AllegraTm 64R centrifuge,
Beckman Coulter) and the resulting supernatant was collected. 27 grams of ammonium
persulfate was slowly added to the supernatant upon continuous stirring at 4 C to obtain
45 % saturation. The resulting solution was centrifuged for 30 minutes at 11500 rpm and
4 *C (Allegra M 64R centrifuge, Beckman Coulter) and the supernatant was collected.
Susequently, 5 mM CaCl 2 was added to the supernatant and the supernatant was loaded
on a phenylsepharose CL-4B column (15 mE of resin per one litre of LB medium, GE
Healthcare) which was pre-equilibrated with a wash buffer A (50 mM Tris, pH 7.5, 500
[M CaCl2 and 1 mM DTT). The column was then washed with wash buffer A until the
absorbance at 280 nm decreased to below 0.03. Subsequently, the column was washed
with wash buffer B (50 mM Tris, pH 7.5, 500 [tM CaCl2 , 1 rM DTT, 0.5 M NaCl) until
the absorbance of the eluent at 280 nm was less than 0.01. Finally, the protein was eluted
using elution buffer (50 Tris, pH 7.5, 5 mM EDTA, 0.15 M NaCl and 1 DTT)
and 2 mE fractions of elute were collected. The concentration of CaM in the collected
fractions was determined using an extinction coefficient of 3300 M1 cm'i at 280 nm
(Hayashi et al. 1998) and the protein purity was checked using 15% SDS-PAGE
electrophoresis, as described below.
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4.2. Isolation of DREAM
Down stream Regulatory Antagonist Modulator (DREAM) was isolated according to the
procedure described previously by Lusin et al. (Lusin et al. 2008). The plasmid
containing the gene for DREAM (Omics Link expression clone, T7 promoter) with C-
terminal His-tag (6 histidine residues) was purchased from Genecoepia and transformed
into E. coli strain BL21 DE3 (Stratagene) through electroporation (Bio-Rad,
MicroPulserm ). For electroporation, 1 [iL of DNA was added to 40 pL of competent
cells and subjected to an electric pulse of 1.8 kV for 5 ms. Transformed cells were grown
on LB agar medium with 100 ig mL- of ampicillin for 12-14 hours at 37 "C. Single
colonies were isolated and used to inoculate one litre of LB medium (pH = 7.0)
containing 100 pg mL 1 of ampicillin. Cells were grown at 37 C and 250 rpm on a
shaker (MaxQ 4000, Barnstead International) until the absorbance at 600 nm reaches an
O.D. between 0.6-0.8. Protein expression was induced by the addition of 0.7 mM IPTG
and cells were grown for an additional 3-4 hours. Cells were then collected by
centrifugation at 8000 rpm at 4 C for 15 minutes (AllegraT M 64R centrifuge, Beckman
Coulter) and then resuspended in a lysis buffer (20 mM Tris-HCl, pH 8.0, 0.3 M NaCl, 1
mM p-mercaptoethanol and 20 % glycerol, 1 mM PMSF, 0.2 % Tween 20 and 1 mM
MgCl 2). Suspended cells were placed on ice and disrupted using a sonic dismembrator
(Fischer Scientific, Model 100) for 30 x 30 seconds and the resulting solution was
centrifuged for 30 minutes at 10000 rpm and 4 0C (AllegraTM 64R centrifuge, Beckman
Coulter). The resulting supernatant was loaded onto a Ni-NTA agarose column (5
PRIME GmbH) which was equilibrated with wash buffer A (20 mM Tris-HCl, pH 8.0,
0.3 M NaCl, 1 mM p-mercaptoethanol and 20 % glycerol). The column was washed with
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a buffer A containing 10 mM imidazole until the absorbance of the eluent decreased
below 0.03 at 280 nm and then was washed with buffer A containing 25 mM imidazole
until the absorbance of the eluent was below 0.01 at 280 nm.
The protein was finally eluted with wash buffer A containing 150 mM imidazole and 2
mL fractions of the eluent were collected and dialyzed against dialysing buffer (10 mM
Tris-HCl, pH 7.4, 1 mM EDTA, 1 mM DTT, 10 mM laurydimethylsulfoxide (LDAO))
for 24 hours to remove the excess of imidazole. DREAM concentration was determined
using an extinction coefficient of 25 x 103 M1 cm 1 at 280 nm (Lusin et al. 2008) and the
protein purity was probed using 15 % SDS gel electrophoresis.
4.3. SDS-PAGE Electrophoresis
Electrophoresis was performed according to the procedure described by Laemmli et al.
(1970). Resolving gel and stacking gel containing 15% and 5% acrylamide, respectively,
were prepared by adding the required amount of acrylamide from a stock solution
containing 30 % acrylamide and 0.8 % N, N'-bis-methylene acrylamide by weight. The
composition of the resolving gel and stacking gel are shown Table 4.2 and 4.3.
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Table 4.2. Composition of the resolving gel
Components Amount
Acrylamide 15 %
Tris-HCl (pH = 8.80) 1.5 M
SDS 10%
Ammonium persulfate 10 %
Tetramethylethylenediamine 0.04 %
Table 4.3. Composition of stacking gel
Components Amount
Acrylamide 5 %
Tris-HCl (pH = 6.80) 0.5 M
SDS 10%
Ammonium persulfate 10 %
Tetramethylethylenediamine 0.04 %
Gel polymerization was initiated by addition of freshly prepared 10% ammonium
persulfate and 0.04 % tetramethylethylenediamine by volume. Gels were prepared on 10
cm glass plates using a SE 600 vertical slab unit (GE Healthcare). The running buffer
used contained 0.025 M Tris, pH 8.3, 0.192 M glycine and 0.1 % SDS. Protein samples
of desired concentrations were prepared in a sample buffer (0.125 M Tris-HCl, pH 6.8, 4
% SDS, 20 % glycerol, 0.02 % bromophenol blue and 0.2 M DTT). Before loading on the
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gel, samples were heated in boiling water for 3 min. Electrophoresis was carried out at a
constant voltage of 120 V with varying current using a power supply (Model FB300,
Fischer Scientific) until the protein samples reached the bottom of the gel. Gels were then
removed from the glass plates and stained overnight using a staining solution (0.1 %
comassie blue R-350, 10 % acetic acid and 20 % methanol). Finally, the gels were then
destained using a destaining solution (10 % acetic acid and 50 % methanol in water).
4.4. Steady state fluorescence spectroscopy
4.4.1. Sample preparation
Steady state fluorescence emission spectra and polarization data were recorded using a
PCi fluorimeter (ISS, Illinois) by using an excitation wavelength of 295 nm. For REES
(Red Edge Excitation Shift) measurements the excitation wavelength was varied from
280 to 300 nm. The apo and Ca2+ bound DREAM samples were prepared by dissolving
DREAM stock solution in 20 mM Tris buffer, pH 7.4, 10 mM LDAO, 1 mM DTT and
adding 1mM EDTA to the apo and 1 mM CaCl 2 to the Ca bound sample respectively.
To prepare Mg2-DREAM, 3 mM MgCl 2 was added to DREAM in the presence of 1 mM
EGTA. In the measurements which used hydrophobic surface probing agents, 10 pM
DREAM was placed in 20 mM Tris-HCl buffer, pH 7.4, 1 mM DTT, 1 mM EDTA or 1
mM CaCl 2 and was incubated with 1 1tM probe (1,8- ANS, 2,6-ANS, or nile red) for 30
minutes at room temperature before the emission spectra were performed. The
wavelengths used for the excitation of 1,8-ANS, 2,6-ANS and nile red were 350, 385 and
552 nm respectively.
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4.5. Frequency domain fluorescence spectroscopy
4.5.1. Theory
The fluorescence lifetime measurements provide information about structural fluctuations
and conformational heterogeneity in the proteins, since changes in the fluorescence
lifetimes reflect structural perturbation in the vicinity of the intrinsic or extrinsic
fluorophore (Ross et al. 2008). Fluorescence decay lifetimes are usually in the range of
picoseconds to a few nanoseconds and can be measured using either a time-domain or
frequency-domain fluorimeter. In time-domain measurements, the fluorescent molecule is
excited with a picosecond pulse and the resulting emission intensity is measured as a
function of time (Berezin et al. 2010). On the other hand, in frequency domain
measurements the fluorescent probe is excited with a sinusoidally modulated high
frequency (o) light. As a result, the emitted light is phase shifted (0D) with respect to the
excitation light and its amplitude is modulated as shown in Figure 4.1. (Ross et al. 2008)
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Figure 4.1. Solid line represents the excitation light. Dotted line represents the emitted
light with a phase shift and modulation amplitude. AC and DC denotes the amplitudes of
the sine wave, where as the subscripts E and F represents excited and emitted light
respectively. Modified from Ross et al. 2008
For a fluorophore with a single lifetime, the lifetime can be determined directly from a
phase shift (0) according to Equation 2 (Ross et al. 2002)
T = tan ((D /o) (2)
The lifetime can also be obtained from the relative modulation values (M) of the
excitation and emission light by using the Equations 3-6.
ME = (ACE) / (DCE) (3)
MF = (ACF) / (DCF) (4)
M = MF / ME (5)
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M= 1 / 2(1+ 0 ) (6)
The wave forms can also be described by the following Equations 7 and 8
J-I (t) sin wt dt
s 0 f (t)dt(7
f I (t) cos rot dt
= fo 1 (t)dt
where I(t) is the impulse response function at any time t. S and G are the sin and cosine
transforms of the impulse response function respectively and ( is the frequency.
In order to characterize the process with multi-exponential decay, the excited light was
modulated over a wide range of frequencies and the corresponding phase shift and
modulation ratios were measured. For a multi-exponential decay the above transforms
can be written as
S .= 1+W2T(
G. J = 1 "(10)
where ai represents the pre-exponential factors, -r represents individual lifetimes and J =
a i-r. The phase delay and modulation ratios can be calculated using Equations 11 and
12
= tan-1 (S/5) (11)
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M= (S2 + G2 ) (12)
The resulting data can be fitted using non linear least square fitting procedure to obtain
the lifetimes and the corresponding pre-exponential factors.
4.5.2. Sample preparation
Frequency domain fluorescence measurements were carried out using Chronos FD
fluorometer (ISS, Champaign, Illinois). A 280 nm LED was used as an excitation source
for Trp excitation. The light source was modulated in the frequency range of 20 to 250
MHz allowing for the resolution of lifetimes up to tens of picoseconds. The standards P-
terphenyl and 2, 5 diphenyl oxazole were used for instrument calibration. The lifetime of
P-terphenyl and 2, 5 diphenyl oxazole was determined previously to be 1.05 and 1.45 ns
(Boens et al. 2007). The data were analyzed using Vinci software (IS) which allows for
data analysis by a single or multi-exponential decay as well as lifetime distribution
models (Gaussian, Lorentzian, etc) to obtain appropriate fits. The quality of the fit was
judged based on X2 and the residual. Samples for the lifetime measurements were
prepared in a similar way as described for samples for steady state measurements. The
sample and the reference concentrations were adjusted in such a way that their integrated
emission intensity at wavelength above 300 nm were identical
4.6. CD-Spectroscopy
CD-spectra were measured on a JASCO-J15 CD-spectrophotometer. The CaM samples
were prepared by dissolving CaM in 20 mM HEPES buffer, pH 7.4, 100 mM KCl, 1 mM
CaCl2 , 1 mM EDTA or 1 mM DM-nitrophen and the spectra were recorded from 200 n
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to 300 nm. DREAM samples were prepared by placing 50 [tM DREAM in 20 mM Tris-
HCl buffer, pH 7.4, 10 mM LDAO, 1 mM DTT, 1 mM CaCl 2 or 1 mM EDTA.
4.7. Photothermal techniques
4.7.1. Theory
Unlike traditional time-resolved spectroscopic studies, photothermal techniques such as
photothermal beam deflection allow for the determination of time-resolved volume and
enthalpy changes in biological and chemical systems. The physical principle behind these
techniques is that a photo-excited molecule decays to the ground state by releasing its
excess excitation energy in the form of heat (Larsen et aL. 2007, Miksovska et al. 2003).
For solvents such as water, such heat release leads to a volume expansion (AVth) that is
associated with a density change as demonstrated in Scheme 4.
Ehv
Heat release
Volume expansion
Density change
index of refraction change
PBD signal
Scheme 4:
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If the photo-excitation of molecules of interest triggers additional photochemical
processes, these processes are associated with a non-thermal volume change (AVnonth) and
contribute to the overall volume change detected in PBD. Such reactions include the
formation/breakage of covalent bonds, change of surface charge distribution, or change in
dimension of the molecule (van der Waals volume). When a pump laser with a Gaussian
profile is used, the change in density leads to a refractive index gradient in the
illuminated volume, which can be probed by monitoring the deflection of a probe beam
that is passed through the illuminated volume. The magnitude of deflection of the probe
beam is directly proportional to the change in the refractive index caused by both the
thermal and non thermal volume changes (AVth + AVnonth).
The observed change in refractive index (An) can be expressed as a sum of three
contributions according to Equation 13.
An = Anth +Anpl + Anv (13)
Anth is proportional to the heat release as shown in Equation 14
Anth ~ (dnldt) (Q pCp) (14)
where dn/dt is the change in refractive index as a function of temperature, Q is the heat
released into the solvent, p is the density and Cp is the specific heat capacity. Anpi
represents the contribution to the PBD signal by any species present in the sample (or any
transient species formed upon photo excitation) that has their absorption maximum at the
wavelength of the probe beam, to the change in refractive index as shown in Equation 15.
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(n=+2) (5)
(18noEo)AN (15)
The term AN is the number of excited molecules per unit volume, E is the vaccum
permittivity and ai is the polarizability of the excited species. In general, the wavelength
of the probe beam is selected in such a way that it is far away from the absorption band of
reactants/products or any transiently populated intermediate which causes the Anpi term
zero to become negligible.
The term Anv0i represents the refractive index change that results from the the changes in
molar volume of the photoexcited species and is represented by Equation 16.
=(e -1)(e +2) (6
6no(AV /)
Where no is the index of refraction of the undisturbed solvent, c is the permittivity of the
solvent and AV is the change in volume. The equations used for the analysis of PBD data
are listed below
S = K Ea [(dn/dt) (1/pCp) Q+ p(dn/dp)AVnonthI+AnPL (17)
R = K Ba Ehv[(dn/dt) (1/pCp)] (18)
(S/R) Ehv Q + [p(dnldp) AVnonth +AnPL/(dnldt)(1/ pCp) (19)
F = ao+ I i [1-exp (t/t1)I (20)
AV AVnonth / (21)
AHr= (Ehv-Q)/ (22)
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According to the Equation 17, the PBD signal for the sample (S) is directly proportional
to the instrument response parameter (K), the number of Einsteins absorbed (Ea), and the
temperature dependent factor (dn/dt)(1/Cpp)Q, where p is the density, Cp is the specific
heat capacity of the solvent. Q represents the heat released into the solvent. The second
term in the Equation 17, p(dn/dp)AVstrreflects the change in the index of refraction due to
non thermal volume change. The p(dn/dp) has a constant value of 0.365 within the
temperature range of our measurements, i.e. between 15-35 C (Eisenberg et al. 1965).
AnPL denotes the "population lens" which includes the contribution to the signal from any
absorbing species at the wavelength of the probe beam (633 nm).
To eliminate the K term in Equation 17, the PBD signal of a reference compound was
measured at the same temperature and instrument alignment as those used for sample
measurements. The reference compound is a molecule that is non-fluorescent, does not
undergo photochemistry, and that releases all its absorbed energy as a heat with a
quantum yield of unity. According to Equation 18, the reference signal (R) is directly
proportional to energy of the photon at the excitation wavelength (Eh,). Since the
reference compound releases all the absorbed energy into the surrounding solvent the
contribution to the observed reference PBD signal in the case of the reference is because
of AVth, The ratio of the equation for the sample and reference PBD signal provides
Equation 19. Using this equation, the non thermal volume change (AVnonth) and the heat
released (Q) for a photo-triggered process can be obtained by plotting (S/R) Eh, versus
(dn/dt) (1/Cpp). AVnonth and Q are then determined from the slope and intercept
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respectively, from the linear fit of the experimental data. For processes that occur
between ~10 ps and 200 ms, the rate constants can be obtained by fitting PBD traces to
Equation 20. From the temperature dependence of the rate constant, the activation
enthalpy is determined from Arrhenius plots. The observed volume and enthalpy changes
correspond to the efficiency of the photo-initiated process. Hence, the observed volume
and enthalpy changes are scaled to quantum yield for DM-nitrophen photodissociation by
using Equations 21, 22, and 23. The change in enthalpy for the fast phase (AHf) is
determined by scaling the difference between the energy of the photon and the heat
released into the solvent to the quantum yield. On, the other hand, the change in enthalpy
(AH,) for the slowphase is obtained by scaling the heat released into the solution to the
quantum yield as shown in Equation 23.
4.7.2. Instrumentation
The pump beam is provided by a 355 nm output (7 ns pulse, Nd: YAG laser Minilite 2,
Continuum, CA) to photo-initiate the reaction. The energy of the excitation pulse was
kept within the linear range of the PBD signal (0 - 1 mJ) to prevent multi photon
absorption. The change in density was probed by using a 633 nm probe beam (cw laser
didode, 3 mW, LASIARIST) as shown in Figure 4.2. The sample was placed in a
temperature controlled cuvette holder (Quantum Northwest, FLASH 300). The probe
beam and the pump beam were collinear and were propagated through the center of the
sample. The diameter of the probe and pump beam were adjusted using pinholes and a
mirror placed behind the sample holder directed the probe beam on the center of a home-
built amplified bicell detector. The magnitude of the deflection of the probe beam was
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measured as a voltage difference between two cells of the detector. The signal was then
digitized using a 500 MHz digitizer (TDS 544A, Tektronix). The data obtained from the
PBD measurements were analysed using Microcal Origin Pro software, version 8.0.
A Amplifier
Pump beam Detector Digitizer
Nd-YAG M2
laser
P2
Probe beam
M3
P' Mi
Sample
B
Figure 4.2. A) Schematic representation of the PBD setup. M and P denotes mirrors and
pinholes, respectively. B) Cartoon picture of transient lens formed in the sample cuvette
and its impact on the probe beam deflection.
4.7.3. Preparation of the sample for the PBD measurement
To minimize the Ca contamination, buffers and solutions were stored in plastic
containers that were previously boiled in distilled water and washed with chelex-100
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treated water. The glassware and the cuvettes were washed with 1 M HCl solution before
each use. For all PBD experiments, potassium ferricyanate (K3[Fe(CN) 6]) was used as a
reference compound. The sample used for DM-nitrophen photolysis measurements
contained 1mM DM-nitrophen dissolved in 20 mM HEPES buffer, pH 7.42, 100 mM
KCl. The concentration of DM-nitrophen was determined using an extinction coefficient
of 4.33 x 104 M- 1 cm~1 at 355 nm (Kaplan et al. 1988). The amount of Ca2+ and Mg 2+
necessary to fully saturate DM-nitrophen was calculated based on the Ka values (shown
in Table 2). Apo-calmodulin was prepared by dialyzing the protein against 20 mM
HEPES buffer, pH 7.42, 100 mM KCl, 1 mM EDTA for 48 hours. The preparation of
apo- CaM was verified using CD spectroscopy. The samples for the PBD measurements
were prepared by dissolving 50 M protein in 20 mM HEPES buffer, pH 7.42, 100 mM
KCl, 450 M DM-nitrophen and 450 [M CaCl 2 .
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5.0 Results
5.1. Electrophoresis
Calmodulin was isolated as described in the Materials and Methods section and its purity
was verified using 15 % SDS-PAGE electrophoresis. The electrophoresis presented in
Figure 5.1 shows a single band at 17 kDa that corresponds to CaM, indicating that the
protein was isolated in a pure form.
A B C
250 kDa-- - -
100 kDa--
75kDa -
50 kDa m
37 kDa
25 kDa -W 9
20 kDa-
15 kDa -
10 k Da - a
Figure 5.1. SDS-PAGE electrophoresis for CaM. A, B, and C represent molecular weight
markers, apo-CaM, and Ca2+ bound CaM, respectively.
5.2. Steady state UV-visible spectroscopy
The absorption spectra of unphotolysed and photolysed DM-nitrophen, Ca 2+-DM-
nitrophen, Mg2+-DM-nitrophen were recorded. The spectra are shown in Figure 5.2. The
absorbance spectra of unphotolysed DM-nitrophen, Mg2+-DM-nitrophen and Ca2' DM-
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nitrophen are similar and show a peak at 350 nm with a shoulder at 305 nm. However,
upon addition of the metal ions, the intensity of the absorption band at 350 nm decreases.
Photolysis of DM-nitrophen is associated with a blue shift of the absorption maximum
from 350 nm to 318 nm with a shoulder at 535 nm. On the other hand, photolysis of
Mg2 +-DM-nitrophen shows an absorption maximum at 300 nm with a shoulder at 321
and 535 nm. In the case of photolysed Ca2+-DM-nitrophen, the absorption spectra show a
peak at 296 nm with a shoulder at 326 and 535 nm. The peak at 535 nm corresponds to
the formation of secondary photoproducts of photodissociation of 2-nitrosobenzaldehyde
because of a long time exposure of DM-nitrophen to UV-light (Wieboldt et al. 2002).
DM-nitropWaveletgedhl(nm)
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5.3. PBD study of the photodissociation of DM-nitrophen
The alignment of the PBD instrument was tested by measuring the reference and sample
PBD signal for the as a function of the number of photons absorbed and as a function of
the power of the pump beam. The data are shown in Figure 5.3 and 5.4. The linearity of
the PBD signal as a function of laser power indicates that the sample or the reference do
not undergo multiphoton absorption within the range of the laser power used. On the
other hand the linearity of the reference PBD signal as a function of absorbance suggests
the absence of the inner filter effect.
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Figure 5.3. PBD signal as a function of the laser power for the sample (triangles) and the
reference compound (squares). Conditions: Reference (K3[Fe(CN) 6]) and the sample (1
mM DM-nitrophen) were dissolved in 20 mM HEPES buffer, pH 7.42, 100 mM KCl.
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Figure 5.4. PBD signal as a function of the number of photons absorbed for the reference
compound. Conditions- K3 [Fe(CN)6]) dissolved in 20 mM HEPES buffer, pH 7.42, 100
MKCl.
Overlays of the PBD traces for the reference, DM-nitrophen, Ca2+-DMnitrophen and
Mg2+-DM-nitrophen are shown in Figure 5.5. In the case of the reference there is a fast
increase in the PBD signal within 20 pts and the signal remains constant for about 200 ms
and then decays back to the baseline because of the diffusion of the heat to the
surrounding solvent. The PB trace for M-nitrophen has a similar time profile as the
reference compound and does not exhibit any detectable kinetics on the 500 ps tirne
scale. However, the amplitude of the PBD signal for M-nitrophen photolysis is smaller
than that of the reference, indicating the presence of thermodynamic events within z < 20
[s. On the other hand the PB signal for Ca2+-DM-nitrophen shows a fast increase
within 20 p s that is followed by slow exponential kinetics with lifetime of 400 s which
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remains constant up to 200 ms. The presence of 400 s kinetics is strongly dependent on
the DM-nitrophen:Ca2+ ratio. Indeed, PBD traces for the photolysis of Ca2+-DM-
nitrophen measured at different ratios of DM-nitrophen: Ca2+ show a decrease in the
amplitude of the slow phase as the ratio of DM-nitrophen to Ca2+ decreases as shown in
Figure 5.6. No slow phase was detected for DM-nitrophen: Ca2+ ratio of 1:2 and higher.
In the case of Mg+ saturated DM-nitrophen, the PBD traces show a rapid increase
similar to the DM-nitrophen signal, without any detectable kinetics between 20 us and
200 ms as shown in Figure 5.7.
4~4
Figure 5.. Overlay of PB traces for potodissociation of M-nitrophen (dotted line)
and the reference compound (thick line) at 2 'C. Conditions: 1 rM M-nitrophen in 20
PE buffer, p 7.42, 100 mM
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Figure 5.6. A) Overlay of PB traces for photodissociation of Ca2+-DMnitrophen
(dotted line) and the reference compound (thick line) at 20 'C. Conditions: 1 mM DM-
nitrophen in 20 rn EPES buffer, pH7.42, 100 rnM KCl, 800 pM CaC12. B) Overlay
PBD traces for different ratios of M-nitrophen: Ca2+.
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Figure 5.7. Overlay of PBD traces for photodissociation of Mgt+-DM-nitrophen (dotted
line) and the reference compound (thick line) at 20 C. Conditions: 1M M-nitrophen
in 20 m HEPES, pH 7.42, 100 m KCl, 5 mMMgCl2.
The volume and enthalpy changes associated with the photodissociation ofDM
nitrophen, Ca)+- M-nitrophen and Mg2-DMnitrophen were determined from the slope
and intercept of the plot of (S /R) Ehvversus Cpp/(dn/dt) using Equation 19. The linea fits
are shown in Figure 5.8 and the extrapolated values for ATV and AHare listed in the Table
5.1. A value of 0.325 was used for the p(dn/dp) term (Eisenberg et al. 1965) and the
AV/AH obtained from the slope and intercept were scaled to a quantum yield of 0.18
which was reported for the photodissociation of M-nitrophen by Kaplan et al. (1988),
according to Equations 21 and 22. The overall volume change of 12 1 mmo1-1 and an
enthalpy change of 63 kcal mo1-1 were observed for the photolysis of M-nitrophen.
Onthe other hand, photodissocitaion of Ca+-DM-nitrophen shows two phases and the
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volume and enthalpy change for each of the phases were determined to be -12 5 mL
moE- and an enthalpy change of -50 20 kcal mole- for the fast phase, and a positive
volume change of 9 3 mL mol 1 and an enthalpy change of -19 13 kcal mol- were
observed for the slow phase. In the case of the photodissociation of Mg2+-DM-nitrophen,
only the fast phase was observed and an overall volume change of 7 2 mL mol and an
enthalpy change of about -40 8 kcal moP' were determined.
Figure 5.8. Plot of (/) Ehv versus {Cpp/(dn/dt)p(dn/dp) for photolysis of D-nitrophen
(squares), Ca2+ DM-nitrophen fast phase (solid circles) and slow phase (open circles), and
g2+0-DM(diamonds).
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Table 5.1. Volume and enthalpy changes determined for photodissociation of DM-
nitrophen, Ca2+-DM-nitrophen and Mg2 -DM-nitrophen from the plot of (SIR) Ehv versus
Cpp/(dn/dt)p(dn/dp) as shown Figure 5.8.
AV A H AV 2  AH2
mL mol' kcal mol mL moP- kcal mol (20 C)
DM-nitrophen 12 1 63 6 - - -
Ca2+ DM-nitrophen -12 5 -50 20 9 3 -19 13 400 [ts
Mg2+-DM-nitrophen -7 2 -40 8 - - -
5.3.1. Thermodynamic parameters for calcium binding to CaM
To determine the volume and enthalpy profile for Ca binding to CaM I have applied
PBD in combination with Ca+ -DM-nitrophen photolysis. The sample preparation for
these measurements is somewhat challenging since [Ca2+Ioai has to be such that DM-
nitrophen is Ca saturated whereas CaM is predominantly in the apo form. The presence
of apo CaM in the Ca+ -DM-nitrophen solution was verified using CD-spectroscopy and
the traces are shown in Figure 5.9. CD-data were recorded for CaM in the presence of
unphotolysed Ca -DM-nitrophen, in the presence of 1 mM EGTA, and after Ca -DM-
nitrophen photolysis using a 355 nm lamp. CD-signal for CaM in the presence of 1 mM
EGTA was measured as a control. The overlay of the CD-signal of CaM in the presence
of EGTA and in the presence of unphotolysed Ca+--DM-nitrophen indicates that the
protein remains in the apo form in the presence of Ca+--DM-nitrophen. Results show that
the irradiation of the CaM- Ca2+-DM-nitrophen sample leads to a 10% decrease in the CD
signal of CaM at 208 and 222 nm in agreement with the previous studies that shown that
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CaM CD signal decreases upon Ca2+ addition because of the increase in a-helical content
(Martin et al. 1986, Zhang et al. 1995) The traces are noisy below 210 nm because of the
presence of DM-nitrophen and EGTA in the samples.
An overlay of the PBD trace obtained for the reference and CaM-Ca2+-DM-nitrophen
sample is shown in Figure 5.10. Comparison of the PBD traces for the photodissociation
of Ca2+-DM-nitrophen and Ca2+-DM-nitrophen in the presence of CaM are presented in
Figure 5.11. The PBD trace in the presence of CaM shows a fast rise in PBD signal
followed by an exponential increase of the signal occurring with a lifetime of about 600
[us and has a higher amplitude for the slow phase compared to the photodissociation of
Ca2+.-DM-nitrophen in the absence of CaM.
0
E -25
N
E -50
N -75
V -100
C)
0) -125Ca
-12 - CaM+ Ca2'DM-nitrophen, dark
o- -CaM+ Ca2'DM-nitrophen, light
-150 
- - - CaM + 1mM EGTA
210 220 230 240 250 260
wavelength (nm)
Figure 5.9. CD spectra of CaM in the presence of Ca2 + saturated DM-nitrophen before
illumination (black trace), upon irradiation with 355 nm light for 5 minutes (red trace)
and in the presence of EGTA (blue trace). Conditions: 50 [uM CaM in 20 mM HEPES,
pH 7.42, 100 mM KCl, 1 mM CaCl2, 1 mM DM-nitrophen or 1mM EGTA.
75
Figure 5. 10. Overlay of PBD trace for the reference (thin line) and the photodissociation
of Ca2+-DM-nitrophen in the presence of CaM (thick line). Conditions: 50 pMCa in 20
mMHPES buffer, pH7.42, 100 m KCl, 450 M M-nitrophen, 450 M CaC12.
7
00j
0
Figure 5.11. Overlay of PBD traces for Ca2+ saturated DM-nitrophen (dotted line), Ca2+
saturated DM-nitrophen in the presence of CaM (thin solid line). Conditions: 450 M
DM-nitrophen in 20 mM HEPES buffer, pH 7.42, 100 mM KCl, 450 M CaCl 2 and 50
PM CaM.
Volume and enthalpy changes associated with Ca binding to CaM were obtained from
the slope and intercept of the linear plot of (SIR) Ehv versus Cpp/ (dn/dt) as shown in
Figure 5.2. The extrapolated values for AV and AH are listed in Table 5.2.
Photodissociation of Ca2 -DM-nitrophen in the presence of CaM is associated with a
volume change of -13 3 mL mole' and an enthalpy change of -61 32 kcal mol 1 for
the fast phase and a volume change 21 2 .L mo- 1 an an enthalpy change of 35 16
kcal mol 1 for the slow phase. The values of volume and enthalpy changes associated
with the fast phase for Ca2+ binding to CaM are comparable to those obtained from the
photo dissociation of Ca2 DM-nitrophen. The kinetics of the slow phase is about 600 s.
77
The rates for the slow phase as a function of CaM concentration were also measured and
are shown in Figure 5.13. From the analysis of the rate of slow phase kinetics as a
function of CaM concentration, using the Michaelis-Menten approach (Equation 24), a
value of 2 x 10- M for KM and 2764 s- for vmax were obtained.
V= Vmax[s] (24)
KM+[S]
where v0 is the initial reaction rate, Vmaxis the maximum reaction rate, S represents the
substrate concentration and Km stands for the Michaelis-menten constant.
Figure 5.12. Plot of (S/R) Eh, versus Cpp/(dn/dt)p for the photolysis of Ca2+DM nitrophen
in the presence of CaM.
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Table 5.2.Volume and enthalpy changes associated with the photodissociation of Ca -
DM-nitrophen in the presence of CaM.
AV 1  AH1  AV2  AH2  r
mL mol- kcal mol mL mol-1 kcal mol-1 (20 C)
CaM+Ca2 -DM-nitrophen -13 3 -61 32 21 2 35 16 600 [us
2600 -
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2200 -
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1400-
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CaM ( M)
Figure 5.13. Kinetics of Ca binding to CaM as a function of CaM concentration.
Conditions: CaM in 20 mM HEPES buffer, pH 7.42, 100 mM KCl, 450 M DM-
nitrophen and 450 M CaC12.
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5.4. Study on DREAM
4.1. Electrophoresis
Down stream Regulatory Antagonist Modulator (DREAM) was isolated as described in
Materials and Methods section and its purity wasverified using 15 % SDS-PAGE
electrophoresis. Electrophoresis is shown in Figure 5.14 and exihibits a single band at 22
kDa that corresponds to DREAM, indicating that the protein was isolated in pure form.
A B C D E F
-- 75 kDa
-
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M, 4.- 10 kDa
Figure 5.14. SDS-PAGE electrophoresis of DREAM. Lane A) eluate with buffer A
containing 10 mM imidazole; B) eluate with buffer A containing 300 mM imidazole; C)
eluate with buffer A containing; D) supernatant; E) cell lysate; F) molecular weight
markers.
5.4.2. CD -Spectroscopy
The CD-spectra were measured for DREAM in the absence and presence of Ca2+ as
shown in Figure 5.15. Addition of Ca2+ to the apo DREAM leads to the decrease of the
CD signal at 222 nm, indicating that Ca 2 ' binding to DREAM results in increase of
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the a-helical content in the DREAM structure. Similar changes in DREAM spectra were
reported previously by Craig et al. (2002). Indeed, an increase in the secondary structure
upon Ca2+ binding seems to be characteristic of EF-hand proteins and it was reported for
CaM (Martin et al. 1986, Zhang et al. 1995) and KChIP 2 (Chen et al. 2006).
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Figure 5.15. CD-spectra of DREAM in the apo and Ca + bound form. Conditions: 10 IM
DREAM in 20 mM Tris buffer, pH 7.42, 10 mM LDAO, 1 mM DTT, 1 mM EDTA or 1
mM CaCl 2.
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5.4.3. Steady state Emission spectra
The steady state emission spectra of DREAM were recorded for apo, Ca2+ and Mg2+
bound forms of DREAM. In the apo form of DREAM, the emission spectrum shows a
maximum at 345 nm. The emission spectrum is blue shifted to 340 nm with a
concomitant decrease in emission intensity upon the addition of Ca 2+. A similar impact of
Ca2+ binding on emission spectra was reported in previous studies by Osawa et al.
(Osawa et al. 2005). The emission spectrum of Mg2+-DREAM is similar to the apo
protein since any change in the emission maxima or emission intensity was not detected.
The emission spectra are shown in Figure 5.16.
1 to
Figure 5.16. Emission spectra of DREAM. Left panel: Emission spectra of DREAM in
the presence (dashed) and absence (solid) of Ca2+. Right panel: Overlay of normalized
emission spectra in apo form (thin line), C2+ bound form (thick line) and Mg2+ bound
form (dashed line). Conditions: 10 [M DREAM in 20 mMTris buffer, H7.42, 10 m
LDAO, 1 MDTT, 1 mM ETA or 1 mMCaC12 or 1 m Mg02.
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5.4.4. Steady state polarization
I used steady-state polarization to obtain information about changes in the DREAM
oligomerization state upon Ca2+ addition. The data are shown Table 5.3. Interestingly my
data did not show any significant differences in the apo and Ca2' bound form of the
protein. At 10 itM DREAM, the polarization values are 0.37 and 0.38 in the apo and Ca2+
bound form of DREAM respectively. On the other hand, the polarization values are
somewhat smaller for DREAM at 87 piM, which showed 0.33 for apo and 0.32 for Ca2 +
bound form.
Table 5.3. Fluorescence polarization data for DREAM in the apo and Ca2+ bound forms.
Conditions: 10 M or 87 ptM DREAM in 20 mM Tris buffer, pH 7.42, 10 mM LDAO, 1
mM DTT, 1 mM EGTA or 1 mM CaCl 2.
Polarization
DREAM (10 pM) DREAM (87 sM)
apo-DREAM 0.37 0.33
Ca2 -DREAM 0.38 0.32
5.4.5. Tryptophan quenching
Steady-state fluorescence quenching studies were carried out to probe the position and
environment of Trp 169 in the apo and Ca2+ bound forms of DREAM. The analysis of
quenching data was performed using the Stem-Volmer Equation 25 (Lakowicz et al.
2010)
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FO/F = 1 + Ksv [Q] (25)
Where FO is the emission intensity before the addition of quencher and F is the emission
intensity in the presence of quencher as shown in Figure 5.17. Ksv is the Stern-Volmer
constant and Q is the concentration of the quencher. Ksv values were obtained from the
slope of the plot of Fo/F versus [Quencher], using acrylamide and KI as quenchers.
Acrylamide and KI are expected to have more accessibility for Trp in the apo DREAM,
as it is more solvent exposed (Osawa et al. 2005).
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Figure 5.17. Right panel: Stern-Volmer plots for quenching of Trp fluorescence by
acrylamide and KI. Left panel: Emission spectra of apo DREAM without quencher (Fo)
and in the presence of 320 mM acrylamide (F). Conditions: 10 and 87 M DREAM is
dissolved in 20 mM Tris buffer, pH 7.42, 10 mM LDAO, 1 mM DTT.
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As expected our data showed higher Ks values for the apo form, indicating that Trp
emission is more quenched in the apo form than in Ca2+-DREAM. Quenching of 10 piM
DREAM with acrylamide provided Ks values of 3.97 0.01 M- and 3.26 0.01 M1 for
the apo and Ca2+ bound forms, respectively. On the other hand, for 87 pM DREAM, the
Ks values were 4.8 0.1 M-1 in apo and 3.9 0.1 M1 in Ca2+ bound form. In the case of
KI, the KS values for quenching of at 10 M DREAM were 4.8 0.1 M and 3.3 0.1
M-1 in apo and Ca2+ bound forms, respectively. The quenching was more effective with
KI. Stern-Volmer plots are shown in Figure 5.17 and the KS values are listed in Table
5.4.
Table 5. 4.Kv values obtained for Trp quenching by acrylamide and KI.
acrylamide KI
Sample KS (M) KS (M-)
apo-DREAM (10 pM) 3.97 0.01 4.82 0.1
Ca2+-DREAM (10 M) 3.26 0.01 3.31 0.1
apo-DREAM (87 [tM) 4.8 0.1 -
Ca2+-DREAM (87 tM) 3.9 0.1 -
5.4.6. Probing the hydrophobic surfaces using 1,8-ANS, 2,6 -ANS and nile red,
Hydrophobic surface probing agents 2,6-ANS, 1,8-ANS and nile red were used to obtain
information about differences in the hydrophobic surface exposure in the apo and Ca2+
bound forms of DREAM. The structures of the probes are shown in Figure 5.18. These
probes have been successfully used to monitor changes in hydrophobic surfaces of other
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proteins (Cocco et al. 1994, Itzhaki et al. 1994, Nishihira et al. 1993). They have a low
fluorescence quantum yield in water but become highly fluorescent upon association to
hydrophobic surfaces (Hawe et al. 2008). However, I could not use these agents in the
presence of LDAO as the probes preferentially interact with the surfactant. Hence,
samples were prepared in the absence of LDAO and steady state emission spectra were
measured. At first I measured the emission spectra of DREAM in the absence of LDAO.
Interestingly, in the absence of LDAO no difference was observed in the emission
spectrum of Trp in apo and Ca"DREAM. Both the spectra showed the same emission
maxima at 332 nm with identical intensity as shown in Figure 5.19. These results are in
agreement with the previous studies that showed LDAO increases the DREAM solubility
and promotes oligomerization of DREAM (Osawa et al. 2005).
H NH SO3
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H3C
Nile red
Figure 5.18. Structures of hydrophobic surface probing agents
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Figure 5.19. Emission spectra of DREAM in the presence and absence of LDAO.
Conditions: 10 M DREAM in 20 mM Tris buffer, pH 7.42, 1 mM DTT in the presence
or absence of 10 mM LDAO.
I measured the steady state emission spectra of 1,8-ANS, 2,6-ANS and nile red in apo
and Ca bound form of DREAM. The obtained spectra are shown in Figure 5.20. In the
absence of Ca2+ the emission spectrum of 2,6-ANS showed an emission maxima at 460
nm. Upon Ca 2+ addition, the emission spectrum is red shifted to 463 nm. On the other
hand, 2,6-ANS showed an emission maximum at 431 nm in the apo form and is blue
shifted to 426 nm in the Ca 2' bound protein. In case of the nile red, the emission
spectrum is very similar in the apo and Ca2+ bound forms of the protein with emission
maximum at 622 nm but with a small increase in the emission intensity in the Ca 2* bound
form. The obtained results show that all the three probes bind to different hydrophobic
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surfaces on the DREAM protein surface and there is larger hydrophobic surface exposed
in Ca' bound form compared to apo protein.
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Figure 5.20. Emission spectra of hydrophobic surface probing agents in buffer and in the
apo and Ca bound form of DREAM. A) 2,6-ANS B) 1,8-ANS C) nile red. Conditions:
10 M DREAM dissolved in 20 mM Tris, pH 7.42, 1 mM DTT, 1 mM CaCl2 or 1 mM
EGTA, 1 M 2,6-ANS or 1,8-ANS or nile red.
5.4.7. REES Spectrum
Red edge excitation shift (REES) measurements were made to probe the mobility of
water molecules in the vicinity of the Trp residue in DREAM (Raghuraman et al. 2005).
The plot of the emission maximum as a function of excitation wavelength did not show
any changes in the maximum of the emission spectrum indicating that the water
molecules are not motionally restricted in the apo or Ca2+ bound forms of DREAM as
shown in Figure 5.21.
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Figure 5.2 1. REES spectra for DREAM in the apo (circles) and Ca2+ bound form
(triangles). Conditions; 10 PMDREAM in20 mMTris buffer, pH 7.42, 10 mM LA , 1
m DTT, E mM TA or 1 mMCaC12.
5.4.8. Fluorescence lifetime data
Fluorescence lifetime of the Trp 169, which is situated in the vicinity of the high affinity
Ca 2+ binding site, EF-hand 3, was measured using a frequency modulation approach to
probe the dynamics of the protein. The data were best fitted to a sums of discrete
exponential decay and Guassian distribution. The fit is shown in Figure 5.22 and the
obtained fitting parameters are shown in Table 5.5. Phase delay (circles) and rnmodulation
ratio (squares) at each frequency in the range of 50 to 250 Mz are shown and the solid
lines represents the fit. The lifetimes obtained in the presence of Mg2+ are similar to that
of the apo form, but upon Ca 2+ binding the equilibrium shifted towards the fraction of the
rnolecules having longer lifetime. Inaddition, the distribution of the 3.20 ns lifetime
becomes broader in the Ca2+ bound form compared to apo form.
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Figure 5.22. Top: Phase delay (squares) and modulation ratio (circles) in the frequency
range of 50 to 250 MHz. Bottom: Residuals of the fit of phase delay (blue) and
modulation ratio (green). Solid lines indicate the fit to sum of the discrete exponential
decays and Guassian distribution. Conditions: 10 tM or 87 M DREAM in 20 mM Tris
buffer, pH 7.42, 1 mM DTT, 10 mM LDAO, 1 mM EGTA or 1 mM Ca2+
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6.0. Discussion
6.1. Photodissociation of DM-nitrophen
Using PBD, the volume and enthalpy changes associated with the photodissociation of
DM-nitrophen, Ca2+-DM-nitrophen, and Mg2+-DMnitrophen were determined. In
addition, using PBD in combination with the caged Ca 2+ compound DM-nitrophen the
volume and enthalpy changes associated with Ca 2+ binding to CaM were determined. The
PBD signal for the photolysis of DM-nitrophen does not show any detectable kinetics
indicating that the photodissociation of this compound is completed within 20 [s. The
observed volume change of 12 1 mL mo 1 and enthalpy change of 63 6 kcal molO
determined for the photolysis of DM-nitrophen are consistent with the cleavage of the
single covalent bond, since the photodissociation of DM-nitrophen involves the cleavage
of three covalent bonds (C-N, N-O, C-H) and concomitant formation of two covalent
bonds (C=O, N-H) as shown in Scheme 4 (Kaplan et al. 1988).
Scheme 4:
In addition previous studies have shown that the volume change associated with
dissociation of a single covalent bond is about 5-10 mL rol-1 (Hunget et al. 1 992.,
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Herman et al. 1987). The reaction enthalpy change can be estimated on the basis of the
bond enthalpies for the covalent bonds cleaved/formed during the photolysis of DM-
nitrophen, and are listed in Table 6.1. The calculated enthalpy value can be compared to
the observed reaction enthalpy change of 63 6 kcal mo- 1 . The difference between the
calculated and observed enthalpy change is because of the fact that the bond enthalpies
strongly depend on the environment in which the bond exists.
Table 6.1. Bond enthalpies for the covalent bonds involved in the photodissociation of
DM-nitrophen
Bonds dissociated AH (kcal mof-) Bonds formed AH (kcal molI)
C-N 71 C=O 167
N-O 120 N-H 91
C-H 98 - -
On the other hand, photodissociation of DM-nitrophen in the presence of Ca2+ shows a
fast phase with a negative volume change of -12 5 m mo-. The fast phase is followed
by a slow phase with a lifetime of about 400 ps at 20 "C. Taking into account the
quantum yield of the photorelease of Ca2+ to be 0.18, the amount of Ca2+ released into the
solution is about 180 M. From this data the bimolecular rate constant for Ca2+ rebinding
to DM-nitrophen is determined to be 13.8 x 106 M4 s-. Similar rate constants were
reported previously for Ca2+ binding to other Ca2+ chelators like EGTA and H-EDTA to
be 2.7 x 106 and 4.5 x 106 M-s 4 respectively (Naraghi et al. 1997). The slow phase
94
exihibits a volume change of 9 3 mL moP- and an enthalpy change of -19 13 kcal
mol-1 . On the basis of those values, the slow phase can be associated with Ca2+ rebinding
to the unphotolysed DM-nitrophen. The observed volume and enthalpy changes
associated with the photodissociation of DM-nitrophen and concomitant Ca2+release
during the fast phase can be represented by Equation 25 and 26
AV 1 = AVDM-nitr+ V0 Ca2+ (25)
ARI = AHDM-nitr + ACHa 2+ (26)
where AVDMnitr represents the volume change that results from the photodissociation of
DM-nitrophen, V ca2+ is the partial molar volume of Ca2+, AHDM-nitr stands for the
enthalpy change as a result of the photodissociation of DM-nitrophen, and AHca2+
represents the enthalpy change because of the solvation of the Ca2+ ion. Substituting the
value of AVDMnitr as 12 1 mL mol- in Equation 25, the partial molar volume for Ca2
was determined to be -24 mL mol 1 which is in agreement with the previously determined
value of -23 mL mol- by Millero et al. (Millero et al. 1971). Similarly, using a value of
61 6 kcal mof- for the enthalpy associated with the photodissociation of DM-nitrophen
in Equation 26, a negative enthalpy change of -110 20 kcal moP- is obtained which can
be attributed to the solvation of the Ca2+ ion in the solution (Gifford et al. 2007., Henzl et
al. 2003).
On the other hand, the reaction volume change of 9 3 mL mol-observed for the slow
phase can be associated with Ca2+ binding to unphotolysed DM-nitrophen. The volume
change for the slow phase is comparable to the volume changes determined for Ca2+
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binding to other Ca2+ chelators like EGTA and HEDTA which were determined to be 13
mL mol-1 and 11.5 mL mo~ 1, respectively, by Kupke et al. (Kupke et al. 1989) using
densimetric techniques. The small change in enthalpy of -19 13 kcal mol' measured for
the slow phase corresponds to Ca2+ rebinding to DM-nitrophen and matches well the
previously observed enthalpy change of 12 kcal molP for Ca2+ binding to other Ca2+
chelators like EDTA determined using isothermal calorimetry (Griko et al. 1999).
Photolysis of Mg2+ -DM-nitrophen exihibits a volume change of -7 2 mL mol1 and an
enthalpy change of -40 8 kcal mol-. I propose that these values correspond to the
photodissociation of Mg 2+-DM-nitrophen with concomitant release of g2+. From the
reaction volume change, the partial molar volume of Mg 2+ is calculated to be -20 mE
mo1 by using Equation 27, as described for the Ca2+ ion. The partial molar volume
determined for Mg2+ is in agreement with the previously reported value of -21 mL mol-
by Millero et al. (Millero et al. 1971). In a similar way by using the value of 63 6 kcal
mol1 for AHDM-nitr in Equation 28, a value of -100 20 kcal mo-1 for AHMg2+ was
obtained and can be attributed to the solvation of the Mg2+ cation.
AV = AVDM-nitr+ VOMg2+ (27)
AH = AHDM-nitr + AHMg2+ (28)
where V*Mg2+ represents the partial molar volume of Mg 2 , and AHmg2+ is the enthalpy
change for the solvation of Mg 2+ cation.
The relationship between the photodissociation of DM-nitrophen and the rate of Ca2+
release is still unclear. Previous studies by Ellis-Davis et al. (Ellis-Davis et al. 1996) and
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McCray et al. (McCray et al. 1992) have used Ca2+ fluorescent indicators in combination
with laser flash photolysis to monitor the rate of Ca2+ release. However, the kinetic data
obtained from these measurements strongly depends on the response time of the Ca2+
indicator used. For example, the Ca-orange-5N fluorophore used by Ellis-Davis et al.
(Ellis-Davis et al. 1996) has a response time slower than 60 ts and those cannot represent
the Ca + release from the DM-nitrophen Photolysis. Thus, by using PBD the rate of
release of Ca2+ from Ca2+-DM-nitrophen was shown to occur within 20 pis concomitantly
with the dissociation of aci-nitro intermediates. Previous transient absorption studies
have shown that the decay of aci-nitro intermediates occurs in two parallel pathways via
cis and trans aci-nitro intermediates and exihibits a biphasic decay with the lifetime of 13
ps and 90 [s at pH 7.2 (Ellis-Davis et al. 1996). However, the relative contribution of the
slower decay is only 30 % and thus it is likely that the contribution of this phase to the
PBD signal is too small to be detected.
Upon complete characterization of the photodissociation of DM-nitrophen and DM-
nitrophen in the presence of Ca2+ and Mg 2+ ions, I determined the volume and enthalpy
changes associated with Ca2+ binding to CaM. Photodissociation of Ca2+-DM-nitrophen
in the presence of CaM showed two phases. The volume and enthalpy changes observed
for the fast phase were about -13 3 mL molP and -61 32 kcal molP, respectively, and
are similar to the Ca2+-DM-nitrophen photolysis. This indicates that the fast phase
involves the photodissociation of DM-nitrophen and concomitant release of Ca2 . On the
other hand, the slow phase of Ca2+-DM-nitrophen in the presence of CaM shows a
volume change of 21 2 mL molP and an enthalpy change of 35 16 kcal moP-. Two
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reactions occur upon photodissociation of Ca2+-DM-nitrophen in the presence of CaM. 1)
The released Ca2+ binds to free unphotolysed DM-nitrophen 2) or Ca2+ binds to CaM.
Previous studies have shown that in the presence of two competing reactions the
efficiency (r )of the each reaction can be determined from their respective rate constants
using Equations 29 and 30 (Abbruzzetti et al. 2000).
1 (29)
172 - (30)k1 +k 2
where k, and k2 are the rate constants for Ca2+ rebinding to unphotolysed DM-nitrophen
and Ca2+ binding to CaM, respectively. Using the rate constants reported in Table 3 and 4
the efficiency for each reaction is calculated to be i = 0.6 and 72= 0.4. From the
efficiency of the reaction the volume change associated with Ca2+ rebinding to
unphotolysed free DM-nitrophen is determined to be 5 mE mol-1. Hence from the
observed volume change of 21 2 mL mo-1 only 16 2 nL mo-1 corresponds to the
volume change associated with Ca2+ binding to CaM. By scaling the volume change of
16 2 mL moP- to the efficiency, 712, a volume change of about 40 mE molP was
determined for Ca binding to CaM. The volume change, occurring on the 300-600 ps
timescale, is consistent with the conformational change in the C-terminal domain, since
490 ps kinetics were determined for the Ca2+ binding to C-terminal domain by Park et al.
using fluorescence spectroscopy (Park et al. 2007). Further evidence for associating the
observed slow phase with Ca2+ binding to CaM was obtained from the increase in the
slow phase kinetics as a function of CaM concentration as shown in Figure 5.13. At CaM
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concentration above 150 riM, the rate for Ca2+ binding is constant with the lifetime of 300
pCs suggesting that Ca2+ binding to CaM is gated by a conformational switch in the C-
terminal domain. The kinetics of 300 [as are in agreement with previously reported data
that showed that the rate of conformational switch in the C-terminal domain occurs
within the lifetime of 390 100 [ s (Malmendal et aL. 1999).
6.2. DREAM
The conformational changes that are triggered by Ca 2+/ Mg 2+ binding to DREAM and
which ultimately lead to a change in the DREAM oligomerization state remains unclear.
Here I used Trp 169 as a probe to monitor the conformational changes occurring in
DREAM upon Ca2+ binding by using steady-state and time-resolved fluorescence
spectroscopy. The emission spectra of DREAM shows emission maxima at 345 nm in
apo form and it is blue shifted to 340 nm upon addition of Ca2 +. The fluorescence
emission data indicates that the Trp residue is more exposed to the solvent in the apo
DREAM and upon Ca2+ binding the Trp moves into a more hydrophobic environment in
agreement with the previous studies by Osawa et al. (Osawa et al. 2005). The emission
spectrum of the apo DREAM is broader than the emission spectrum of Ca bound form,
suggesting that the structure of Ca2+-DREAM is more compact and less heterogenous
compared to the apo form. This is also evident from the increase in a-helical structure in
Ca2+-DREAM. The emission spectrum measured in the presence of Mg 2+ is similar to
that of the apo form without any change in the emission maximum. One possible reason
might be that the Mg 2+ binding site (EF-hand 2) is relatively far away from Trp 169 and
the Mg 2+ induced conformational changes may not impact fluorescence properties of Trp.
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The data obtained from the Red edge excitation shift spectrum did not show any
significant changes in the emission maximum of Trp as a function of excitation
wavelength, suggesting the absence of motionally restricted water molecules in the
vicinity of the Trp either in apo or Ca2+ bound form. Quenching studies were carried out
using acrylamide, a neutral quencher, and iodide, an anionic quencher. The Ks values
determined for quenching of Ca2+-DREAM by KI and acrylamide are similar and smaller
than Ks,, for apo-DREAM. Interestingly KI is a stronger quencher of apo DREAM
suggesting that the Trp 169 is surrounded by positively charged residues in the apo form.
NMR structure of Ca2+ DREAM shows two positively charged residues in the vicinity of
Trp 169 (Lusin et al. 2008). The conformational switch associated with Ca2+ binding may
likely bring Trp residues closer to these lysine residues.
The emission spectra of hydrophobic surface probing agents 2,6-ANS, 1,8-ANS, and nile
red show an increase in the emission intensity in the presence of DREAM indicating the
probes binding to the proteins hydrophobic surface. The emission intensity for all three
probes increases upon Ca 2+ binding indicating a larger exposure of the hydrophobic
surface in the Ca2+ bound form compared to the apo protein. The increase in the emission
intensity upon Ca2+ binding indicates the exposure of a larger hydrophobic surface in the
Ca 2+ bound form which may be important for DREAM dissociation from DNA. These
data suggests that in the apo form, the protein surface is more hydrophilic and it promotes
DREAM interaction with DNA. As a result of Ca2+ induced conformational changes, the
exposed hydrophobic patches cause the DREAM to dissociate from DNA and
preferentially form dimers.
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Fluorescence lifetimes of Trp 169 were determined in the presence and absence of Caz
using frequency domain fluorescence measurements to obtain information about the
protein dynamics on nanosecond time scale. The presence of bi-exponential decay
indicates that the protein exists in two different conformations with different tryptophan
environments. Calcium association shifts the equilibrium towards the conformation with
tryptophan residue located inside the protein. In the apo form the fraction of the
molecules having longer lifetime (3 ns) are in higher proportion compared to the number
of molecules having a shorter lifetime (1 ns). However, upon Ca2+ binding the
equilibrium shifts towards the conformation with a 1 ns lifetime as a result of Ca2+
induced conformational changes.
I expected to see large differences in steady state polarization values since there is a
change in the oligomerization state of DREAM from tetramer to dimmer upon Ca+
binding. Interestingly, we did not see any significant differences between the apo and
Ca2 + bound forms which may be attributed to the difference in the Trp lifetimes since, in
addition to the change in the oligomerization state of DREAM, there is a concomitant
change in the Tr lifetimes. Quenching studies, polarization and lifetime data were
measured at lower (10 [iM) and higher (87 [M) concentrations. The reason for choosing
two different concentrations is that, DREAM at higher concentrations was used a control,
since, previous studies showed that at 87 tM, DREAM exists as a tetramer in apo form
and as a dimer in Ca2 + bound form (Osawa et al. 2001). We did not see any significant
differences between the range of concentrations used indicating the strong affinity of
DREAM monomers to form higher order aggregates.
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6.0. Conclusion
The mechanism associated with the ability of the CaBPs to undergo conformational
changes and regulate various cellular processes in a Ca 2+ dependent manner is still not
clear. A detailed understanding of transduction of the Ca2+ signal into a biological
response requires thorough knowledge of the dynamics and energetics associated with
Ca2+ binding to Ca2+ transducers. By using PBD in combination with caged Ca2+
compound, DM-nitrophen, the kinetics of Ca2+ binding to the C-terminal domain of CaM
was determined to be 600 [ts. A positive volume change of 40 mL mol1 associated with
Ca2+ binding to the C-terminal domain of CaM suggests the exposure of hydrophobic
patches as a result of Ca2+ induced conformational changes and concomitant
reorganization of the water molecules. As a part of this study, photodissociation of DM-
nitrophen, Ca2+-DM-nitrophen and Mg2+.-DM-nitrophen has been characterized using
PBD. In case of Ca+-DM-nitrophen and Mg2+ DM-nitrophen, the PBD data showed that
Ca release occurs witin 20 [,s after photolysis. Steady-state fluorescence spectroscopy
was used to probe the conformational changes associated with Ca2+/g 2+ binding to
DREAM in the vicinity of the Trp 169 and results show that Trp is more solvent
accessible in the apo form, and upon Ca2+ binding Trp moves into more hydrophobic
environment. Finally, time-resolved fluorescence spectroscopic study on DREAM
suggest that DREAM exists in dynamic equilibrium between two conformations and Ca2+
binding promotes the conformation with Tp buried within the protein.
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